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ABSTRACT 
 
The highly conserved protein CTCF (CCCTC-binding factor) participates in 
many epigenetic regulatory functions, including insulation, imprinting, X chromosome 
inactivation, and both transcriptional activation and repression.  Recent data has also 
suggested a prominent role for CTCF in mediating interactions between chromosomes 
and in the global organization of the nucleus. In this work, we initiated a functional 
analysis of CTCF to determine the regions of the protein necessary for regulating 
transcription and altering chromatin structure.  As a reporter for changes in chromatin, we 
employed a cell line bearing a lac operator array that can dramatically unfold its normally 
condensed chromatin when targeted by transcriptional proteins fused to a GFP-tagged lac 
repressor DNA binding domain.  With this system, we demonstrated that CTCF-lac 
repressor fusions induced substantial decondensation of the array and we have mapped 
the opening activity to portions of the N- and C-terminal regions of the protein.  In 
addition, we mapped a transcriptional activation domain in CTCF‟s NT-region (NTAD) 
that recruits HATs and chromatin remodeling proteins similar to acidic activators.  The 
C-terminal also has two opening domains, but they do not activate transcription.  
Moreover, arrays opened by the CT region adopt structures morphologically distinct from 
the NTAD and other activator proteins.  The unique CT-induced structures require an 
AT-hook motif that appears to bring disparate portions of the array together.  Thus, the 
conserved AT-hook may contribute to the tethering activity of CTCF during DNA loop 
formation at endogenous loci.   
In addition to assessing chromatin opening, we have demonstrated the utility of 
the array system as an in vivo method for cofactor recruitment by confirming co-
localization of known CTCF protein partners to a targeted array.  Therefore, this system 
also provided an assay to identify the recruitment domains for each partner.  We revealed 
that the cohesin complex is recruited by CTCF through the NTAD, which provides the 
first evidence that an activation domain can recruit the cohesin complex.  We also 
clarified CTCF‟s interaction to the remodeling protein CHD8 by showing its functional 
recruitment to the array through one of the CT-opening domains.  Additionally, we 
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differentiated the three domains in CTCF that are sufficient to initiate decondensation of 
chromatin structure by ascertaining the co-factors recruited to the array by each domain.   
Finally, with this system we found and analyzed SUMO-motif sites in the NT- 
and CT-regions.  Our data suggests that sumoylation of the NTAD reduces its 
transactivation and chromatin opening activities, while sumoylation of the CT region 
demonstrated enhancer blocking activity.  This is the first study to elucidate an enhancer 
blocking domain for CTCF and suggests a mechanism for directing this activity to 
specific loci via a post-translational SUMO-modification.  We have demonstrated a direct 
role in altering chromatin structure, elucidated several of the diverse transcriptional 
regulatory domains in CTCF and further characterized the co-factors potentially involved 
with CTCF function.   
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CHAPTER 1: THE EPIGENETIC REGULATOR CTCF 
 
INTRODUCTION 
The eukaryotic genome is packaged into multiple levels of chromatin structure.  
Linear DNA wrapped around histones (nucleosomes) forms the fundamental units of 
chromatin, and subsequent packaging and folding of nucleosomes generates higher-
ordered chromatin.  Over the past few decades, research on local chromatin has 
demonstrated dynamic interactions between transcription factors and the nucleosomes.  
These factors can establish heritable epigenetic marks such as DNA methylation and a 
“histone code” that help regulate gene expression (Bernstein et al., 2007).  Consequently, 
both the genetic and epigenetic integrity of the genome is essential for how cellular 
processes such as transcription, differentiation, and proliferation are controlled.    
Recent technological advances have emphasized the significant role that higher-
ordered chromatin structures play in how the cell processes DNA response elements.  
Studies of transgene arrays with high resolution microscopy, the chromosome 
conformation capture (3C) method and genome-wide analyses have elucidated more 
complex regulation through chromatin structures and long-range chromosomal 
interactions (Belmont et al., 1989; Dietzel et al., 2004; Hu et al., 2009; Johnson et al., 
2007).  Higher-order chromatin contributes to more precise transcriptional control by 
properly positioning regulatory elements and their transcriptional machinery to 
designated sub-nuclear targets. Higher-order chromatin structures include active 
chromatin hubs and transcriptional factories as well as inter- and intra-chromosomal loop 
formations (Reik et al., 2004; Wallace and Felsenfeld, 2007).  While some of these 
structures are likely a result of sharing common resources within nuclear sub-
compartments, the growing list of identified chromatin associations suggest that many of 
these structures are designed regulatory interactions.   
Beyond the formation of DNA loops, the global positioning of the chromosomes 
within the nucleus create areas known as chromosome territories (Chambeyron and 
Bickmore, 2004; Meaburn and Misteli, 2007).  The spatial arrangement of the 
chromosomes is generally organized with gene dense regions located toward the center of 
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the nucleus and gene deficient regions at the periphery of the nucleus (Cremer and 
Cremer, 2010).  Interestingly, the positioning of genes within these chromosome 
territories and their subsequent association with other genes and sub-nuclear structures 
can affect their function within a given cell-type (Khalil et al., 2007).  Collectively, 
research on the compartmentalization of chromatin and the architecture within the 
nucleus has generated a dynamic three-dimensional model for the regulation of multiple 
cellular processes.  However, many questions remain on how this model is initiated and 
maintained as well as what key factors are involved in ultimately regulating the 
chromatin structure. 
 
 
CCCTC-BINDING FACTOR 
Understanding how gene expression patterns are established and maintained in a 
3-D nuclear model has been of great interest.   Although the mechanism of action is still 
unknown, recent evidence has implicated the protein CCCTC-binding factor (CTCF) as a 
likely candidate in organizing and maintaining the three-dimensional structure within the 
nucleus.  This introductory chapter will review our current understanding of CTCF, its 
properties and functions, and how it might act as a coordinator of chromatin organization 
(Phillips and Corces, 2009).  A timeline of significant CTCF discoveries is in Table 1.  
CTCF was first discovered as a negative regulator of the MYC gene in both 
mammals and birds, binding to a CT-rich DNA element in the c-myc promoter 
(Lobanenkov et al., 1990).  Subsequently, CTCF was found to be ubiquitously expressed 
in almost all adult tissues in vertebrates.  An orthologous CTCF in Drosophila (dCTCF) 
was also found to have a similar domain structure and binding site specificity (Moon et 
al., 2005).  CTCF contains an eleven zinc-finger (ZFs) DNA binding domain (DBD) that 
is capable of binding divergent sequences beyond the originally discovered MYC gene 
CT-rich region.  CTCF binding sites have been termed CTSs (CTCF target sites) 
(Klenova et al., 2001; Rasko et al., 2001).  Early studies showed that CTCF‟s DNA 
footprint at many of these CTSs is a rather large 50-75 bp (Ohlsson et al., 2001).   
CTCF‟s ability to bind multiple sequences via different combinations of its ZFs led to its 
classification as a “multivalent protein” (Filippova et al., 1996).    The ZFs have nearly 
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100% homology between mouse, human, and chicken, while the N- and C-terminal 
regions are nearly as conserved.  CTCF‟s conservation and ubiquitous expression suggest 
an essential role in gene regulation.   
Recent mapping of CTCF‟s genome-wide occupancy was used to establish a 
consensus CTS motif.  Due to the differences between individual CTCF binding sites, it 
has been difficult to elucidate a consensus motif (Ohlsson et al., 2009).  More recently, 
however, several independent genome-wide chromatin immunoprecipitation (ChIP) 
assays using hybridization to tiling-arrays of non-repeat sequences (ChIP-on-chip) or 
ChIP with parallel DNA sequencing (ChIP-seq) have established a common CTS motif 
(Boeva et al., 2010; Jothi et al., 2008; Kang et al., 2009; Rubio et al., 2008).  
Computational methods have converged on a consistent ~11-15 bp invariant core  
(CCnnnnGnnGGC) as a consensus CTCF binding sequence (Ohlsson et al., 2009).  This 
core sequence appears to use the central 4-5 zinc fingers, whereas stepwise deletion 
analyses of CTCF‟s ZFs have indicated that the peripheral zinc fingers help stabilize 
DNA-binding and possibly provide different functionality according to binding affinity 
and conformation (Ohlsson et al., 2001; Renda et al., 2007).  The number of predicted 
CTCF-binding sites has varied in the different cell types studied (~10,000 to 40,000 
sites).   
Genome-wide studies have also shown that CTCF does not follow the same 
distribution patterns as other transcription factors.  For example, Kim et al. demonstrated 
that CTCF-binding sites correlate with gene dense clusters with a similar coefficient to 
the transcription factor TAF1 (Kim et al., 2007b).  However, closer examination of these 
factors showed that only 20% of CTCF-binding sites are close to the promoter (within 2.5 
kb), whereas greater than 85% of TAF1-binding sites are found within this range.  In 
another study using ES cells, ChIP-Seq analyses on several transcription factors revealed 
over 3500 clusters containing at least 4 transcription factors that were termed “multiple 
transcription factor-binding loci” (MTLs) (Chen et al., 2008; Degner et al., 2009; Wan 
and Bartolomei, 2008).  Only a low percentage of CTCF-binding sites were associated 
with MTLs and CTCF‟s binding patterns did not coincide with gene expression patterns 
in ES cells (Chen et al., 2008).  On the other hand, a different study showed that CTCF 
has parallel distribution patterns to the transcription factors STAT1 and NSRF (Boeva et 
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al., 2010; Jothi et al., 2008).  The broad distribution and large number of CTCF sites 
found in these genome-wide studies support the hypothesis that CTCF has an essential 
role in nuclear organization and gene regulation (Phillips and Corces, 2009).     
Consistent with CTCF‟s potential role as an essential protein in gene regulation, 
two different studies showed that homozygous knockout of CTCF in mice is an 
embryonic lethal at the pre-implantation stage (Heath et al., 2008).  Another study by 
Wan et al. demonstrated that RNAi-mediated depletion of CTCF in oocytes inhibits 
progression past the blastocyst stage (Wan et al., 2008).  Additionally, conditional 
knockout of CTCF in αβ T cells and T helper 2 cells showed that it is essential for cell 
cycle progression and cytokine expression, respectively (Heath et al., 2008; Sekimata et 
al., 2009).  Ectopic overexpression of CTCF or depletion via RNAi results in aberrant 
effects on cell growth, proliferation, differentiation, and apoptosis (Klenova et al., 2002; 
Nativio et al., 2009).  Taken together, these results indicate that CTCF has a large-scale 
role in gene regulation that is essential for cellular function. 
 
 
FUNCTIONAL PROPERTIES 
 When it was first discovered, CTCF was reported to be a transcriptional repressor 
based on transient transfections of reporter plasmids driven by the c-myc promoter from 
chicken, mouse, and human (Filippova et al., 1996; Lobanenkov et al., 1990).  
Concurrently, Negative protein 1 (NeP1) was discovered at the chicken lysozyme gene as 
a synergistic negative regulator that binds a composite element containing a thyroid 
hormone response element (Baniahmad et al., 1990).    Characterization of NeP1 and 
CTCF revealed that these were the same protein (Burcin et al., 1997).  CTCF further 
demonstrated its versatility at the chicken lysozyme gene, where it synergistically 
activates and represses transcription in conjunction with the thyroid hormone receptor 
(Burke et al., 2002; Lutz et al., 2000a; Lutz et al., 2003; Weth et al., 2010).  The CTCF 
site alone, however, has little effect on lysozyme transcription.  CTCF was also found to 
bind and activate the Amyloid β-Protein Precursor promoter (Vostrov and Quitschke, 
1997; Vostrov et al., 2002; Yang et al., 1999).  Taken together, the variable results 
suggest that CTCF‟s transcriptional activity is highly context-dependent and most likely 
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reflects the location of the recognition elements relative to the TATA box, their proximity 
to other transcription factor binding sites, and cell type specific cofactors.   
More recent studies have also shown that CTCF can both activate and repress 
transcription at several gene loci.  Specifically, CTCF cooperates with CIITA and 
regulatory factor X (RFX) to activate the human major histocompatibility complex class 
II (MHC-II) genes HLA-DRB2 and HLA-DQA1 (Majumder et al., 2006; Majumder et 
al., 2008).  Conversely, CTCF has been shown to repress transcription at both the hTERT 
and PAX6 genes (Canto-Soler et al., 2008; Choi et al., 2009; Li and Lu, 2005; Li et al., 
2004, 2006; Renaud et al., 2007; Renaud et al., 2005; Wu et al., 2006).  As a whole, 
CTCF appears to influence transcription at specific loci and throughout the genome via a 
mechanism that may be distinct from traditional transcription factors.   
While the previous studies are still heavily cited as the basis for CTCF‟s function, 
it remains unclear how significant CTCF‟s role is as a classical transcription factor.  
Although in vitro experiments localized transcriptional activation to its N-terminal 
region, neither the necessary co-activators nor the activation domain of CTCF have been 
well characterized (Vostrov et al., 2002).  A few limited studies on CTCF structure 
generally localized transcriptional activation to its N-terminal region and transcriptional 
repression to all three regions (the N-terminal, C-terminal, and ZFs) (Figure 1) (Awad et 
al., 1999; Klenova et al., 2001; Lutz et al., 2000b; Ohlsson et al., 2001; Vostrov et al., 
2002).  One detailed study mapped a small repression motif in the N-terminal region, but 
no further functional details have emerged (Drueppel et al., 2004).  Examination of 
CTCF‟s repression activity has given variable results, with repression activity found in 
the N-terminal, C-terminal or zinc finger regions (45).  In addition, both the domains of 
CTCF that show repression and the level of the repression differ depending on the cell 
type examined (Drueppel et al., 2004; Lutz et al., 2000b).  Little is known about the 
mechanism of repression by CTCF, but interaction with the corepressor mSin3a has been 
demonstrated (Lutz et al., 2000b). 
CTCF and insulators or chromatin boundaries 
While CTCF‟s specific role in transcription is still not fully understood, perhaps 
the most significant milestone in studies of CTCF occurred when Bell et al. discovered 
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that CTCF binds to the 5‟HS4 locus control region (LCR) at the chicken β-globin locus 
(Bell et al., 1999; Saitoh et al., 2000).   This discovery was the first to implicate CTCF or 
any vertebrate protein as an insulator protein. 
The propensity of heterochromatin to spread into neighboring regions and the 
ability of enhancers to act over long distances highlight the necessity to have an 
epigenetic control that maintains independent units of gene regulation.  Insulators or 
chromatin boundaries are DNA elements that were defined by their ability to protect a 
gene from potentially inappropriate signals in the surrounding environment (Figure 2).  
The first sequences identified with insulator activity were found in Drosophila at the 
gypsy retrotransposon and the scs/scs’ elements of Hsp70 (Gdula et al., 1996; 
Gerasimova and Corces, 1996; Kellum and Schedl, 1991, 1992).  Transgene studies of 
these elements showed that insulators have two inherent activities.  First, insulators act as 
a boundary or barrier that prevents transcriptional repression due to the spread of 
heterochromatin.  Second, insulators act as enhancer blockers that prevent erroneous gene 
activation when situated between a promoter and enhancers.  This enhancer blocking or 
“EB” activity provides one example for how the long-range action of eukaryotic 
enhancers can be targeted to specific promoters.    
Our understanding of how insulators work initially came from Drosophila studies 
of the proteins that bind them.  The gypsy insulator contains multiple binding sites for the 
zinc-finger DNA binding protein, suppressor of Hairy-wing [Su(Hw)], which also 
associates with many endogenous sites in the Drosophila genome (Gdula et al., 1996; 
Gerasimova and Corces, 1996).  Su(Hw) interacts with the POZ-domain proteins, CP190 
and Modifier of mdg4 [Mod(mgd4)], and the ubiquitin ligase, Topors (Chen and Corces, 
2001; Pai et al., 2004; Ramos et al., 2006).  Together, these proteins form nuclear sub-
structures known as insulator bodies, which are thought to represent the convergence of 
multiple insulator complexes associated with different Su(Hw) sites (Pai et al., 2004). In 
addition, Topor‟s interaction with the nuclear lamina may provide an anchor for insulator 
bodies (Capelson and Corces, 2005).  By bringing distant chromosomal regions together, 
the insulator complexes would create large scale chromatin loops that may represent 
independently regulated domains. Similarly, the scs and scsʹ elements require the 
insulator proteins, zeste-white5 and boundary-element-associated factors, to form a 
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chromatin loop that contains the Hsp70 gene (Blanton et al., 2003; Jiang et al., 2009).  
Thus, in Drosophila, insulator activity appears to be mediated through higher-order 
chromatin structure.   
CTCF was the first vertebrate protein found to have insulator activity (Bell et al., 
1999).  Similar to the Drosophila elements, the 5‟HS4 insulator has also shown evidence 
for higher-ordered chromatin structure (Hou et al., 2008; Yusufzai and Felsenfeld, 2004).  
Shortly after its discovery at the β-globin locus, four CTCF-binding sites were identified 
by several groups at the imprinted Igf2/H19 genes and shown to possess insulator activity 
at this locus (Bell and Felsenfeld, 2000; Hark et al., 2000; Kanduri et al., 2000; Szabo et 
al., 2000; Wolffe, 2000; Wylie et al., 2000).  This discovery provided the first in vivo 
vertebrate study of insulator function and led to more intense research into the 
mechanism behind this epigenetic control.  Located between Igf2 and H19 is the 
imprinting control region (ICR) that binds CTCF in a DNA methylation-dependent 
manner (Figure 3) (Hark et al., 2000; Kanduri et al., 2000).  When bound to the 
unmethylated ICR in the maternal chromosome, CTCF blocks enhancers from activating 
the maternal Igf2, while allowing expression of H19.  On the paternal chromosome, DNA 
methylation of the ICR inhibits CTCF binding, thereby allowing enhancer activation of 
Igf2.  In addition to allowing activation of maternal Igf2, mutations that prevent CTCF 
binding to the ICR also lower H19 expression, suggesting that CTCF simultaneously 
activates H19 while blocking transcription of Igf2 (Schoenherr et al., 2003; Verona et al., 
2008).   
After the discovery of CTCF-binding sites at the ICR, multiple sequences have 
been reported to bind CTCF and exhibit EB activity.  CTCF has been implicated in 
regulating several other imprinted genes, such as Rasgrf1, Kcnq1, Cdkn1c, and MEG3 
(Fitzpatrick et al., 2007; Rosa et al., 2005; Yoon et al., 2005).   To date, all characterized 
vertebrate insulators utilize CTCF for their EB activity and it is the only known 
vertebrate protein to bind insulators (Lewis and Murrell, 2004; Phillips and Corces, 
2009). 
While its EB blocking activity is well established, the barrier activity of CTCF is 
less defined. The 5‟HS4 insulator prevents transgene silencing by heterochromatin, but 
CTCF is neither necessary nor sufficient for the barrier activity of the 5‟ HS4 insulator, 
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which suggests that it generally does not prevent the spread of heterochromatin (Recillas-
Targa et al., 2002). Its barrier activity, however, may be locus-dependent, as CTCF has 
been reported to constrain the spread of heterochromatin from the CTG repeat in the 
myotonic dystrophy type 1 locus and maintain the active chromatin region for the p16 
gene locus (Cho et al., 2005; Witcher and Emerson, 2009).  Moreover, Cuddapah et al. 
used ChIP-seq to map the genome-wide binding sites of CTCF in three cell types and 
identified significant binding of CTCF to the boundaries between the repressive 
chromatin regions marked by H3K27me3 and the active H2AK5ac regions (Cuddapah et 
al., 2009).  
The mechanism of CTCF‟s EB and barrier activities are unknown, but appear to 
involve local and higher-order chromatin structures. At the local level, CTCF bends DNA 
and creates nuclease hypersensitive sites (Arnold et al., 1996; Hark and Tilghman, 1998). 
In addition, CTCF binding is associated with histone acetylation at some loci, and CTCF 
site mutations within the ICR result in loss of histone modifications and an increase in 
DNA methylation (Fitzpatrick et al., 2007; Han et al., 2008; Splinter et al., 2006; Verona 
et al., 2008). On a larger scale, chromosome conformation capture (3C) studies of the 
mouse β-globin locus show that a CTCF-bound portion of the LCR interacts with regions 
containing CTCF sites located about 60 and 85kb upstream of the gene and one in a 3‟ 
flanking position (Palstra et al., 2003; Splinter et al., 2006). Deletion of the CTCF gene 
abrogates these long-range interactions (Splinter et al., 2006). At the Igf2/H19 locus, 
maternal chromosome-specific interactions were identified between the CTCF-bound 
ICR and the promoters of the silent Igf2 gene (Kurukuti et al., 2006; Murrell et al., 2004; 
Yoon et al., 2007). The maternal ICR also appears to form chromatin loops with  
downstream enhancers and the H19 promoter (Yoon et al., 2007).  In addition to long-
range cis interactions, CTCF is required for inter-chromosomal pairing between the 
Igf2/H19 and Wsb1/Nf1 loci (Ling et al., 2006).  These results suggest that CTCF can 
direct changes in local chromatin structure and also plays a role in establishing or 
maintaining large chromatin loops between distant regulatory regions.    
CTCF‟s role in the epigenetic switch for X-inactivation provides another well-
studied example of CTCF function (Boumil et al., 2006; Chao et al., 2002; Donohoe et 
al., 2009; Goto and Kimura, 2009; Lee, 2003; Pugacheva et al., 2006).  Similar to the 
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Igf2/H19 imprinted locus, differential methylation has been proposed to affect CTCF-
binding patterns on the X-chromosomes (Boumil et al., 2006).  CTCF and Yy1 
collaborate in the regulation of X-chromosome inactivation through numerous paired 
sites between the Xist and Tsix genes (Boumil et al., 2006; Donohoe et al., 2007).  
Moreover, CTCF has been shown to be essential for X-chromosome pairing (Xu et al., 
2007).  Recently, the pluripotent factor Oct4 has been shown to interact with CTCF to 
control X-chromosome pairing and counting  (Donohoe et al., 2009).  Additionally, Oct4 
and CTCF appear to act in concert at several imprinted loci in establishing differential 
methylation domains (DMDs) [Zimmerman, unpublished].  Finally, CTCF has been 
shown to direct both transcriptional and chromatin boundary activity at the X-
chromosome inactivation center (Goto and Kimura, 2009; Orishchenko et al., 2009).  
Taken together, CTCF has been shown to affect enhancer blocking, activation and 
repression and their mechanism likely involves the establishment of higher-ordered 
chromatin.  However, our understanding of how these activities might communicate in 
concert or as contextual, functional components has been poorly understood.  Similar to 
the Drosophila insulator models, understanding CTCF‟s functions will likely require 
determining the regulatory proteins that interact with CTCF. 
 
INTERACTING PROTEINS 
To date, several proteins have been shown to associate with CTCF that likely 
influence its functional activities (Zlatanova and Caiafa, 2009).  The growing list of 
recognized CTCF-interacting proteins has been identified through yeast two-hybrid 
screens, mass spectrometry, and sequence analysis (summarized in Figure 4).  For 
example, CTCF interacts with the nuclear matrix and the nucleolar protein 
nucleophosmin, which might act as anchoring units to loop formation by CTCF 
(Yusufzai and Felsenfeld, 2004; Yusufzai et al., 2004).  Other protein partners such as 
Yy1, Suz12, and CHD8 have been shown to influence CTCF-binding and the chromatin 
dynamics at specific loci, such as the X-chromosome Inactivation center or the H19/Igf2 
imprinted locus (Donohoe et al., 2007; Ishihara et al., 2006; Li et al., 2008).  These 
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interactions, however, need to be further characterized to determine their functional 
relevancy. 
Similar to the Su(Hw) insulator complex, CTCF has been proposed to form 
insulated regulatory units by tethering different chromosomal regions to each other or to 
nuclear sub-structures (73).  Although insulator bodies have not yet been reported in 
vertebrates, dCTCF co-localizes with the Su(Hw) complex at insulator bodies 
(Gerasimova et al., 2007; Moon et al., 2005).  In this complex, the DNA-binding domains 
to dCTCF and Su(Hw) help stabilize the protein CP190 in loop formation (Gerasimova et 
al., 2007).  The Drosophila model provides an excellent example of how CTCF and 
insulator proteins regulate nuclear architecture (Kim et al., 2007b; Mukhopadhyay et al., 
2004).  It remains to be seen, however, if CTCF forms insulator bodies.  
The cohesin complex is another recently discovered partner that co-localizes with 
CTCF at many loci and may provide part of the tethering activity needed to hold distant 
regions together (Nativio et al., 2009; Parelho et al., 2008; Stedman et al., 2008; Wendt 
and Peters, 2009; Wendt et al., 2008).  Moreover, cohesin is required for the enhancer-
blocking activity of CTCF at several loci (Wendt and Peters, 2009).  To address whether 
cohesin affects higher order chromatin, Wendt et al. used 3C assays and RNAi-mediated 
depletion of the cohesin subunits to show that cohesin has a critical role in maintaining 
CTCF-mediated chromatin conformation at the IGF2-H19 locus in human cells.  
Disruption of this conformation coincides with changes in IGF2 expression.  This 
conformation exists independent of cohesin's function in sister chromatid cohesion and 
the cohesin complex likely aids CTCF in mediating cis-interactions between DNA 
molecules (Nativio et al., 2009).   
Post-translational modifications 
In addition to protein partners, several post-translational modifications of CTCF 
have been identified.  Since different CTSs can mediate distinct CTCF functions in 
transcriptional regulation and insulator activity, posttranslational modification may 
modulate CTCF activities.  One studied examined CTCF‟s CKII phosphorylation sites in 
the CT region and showed that mutations blocking phosphorylation markedly enhanced 
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repression at the vertebrate c-myc promoters.  Moreover, these substitutions manifested a 
profound effect on negative cell growth regulation by wild-type CTCF (Klenova et al., 
2001).   
More recently, the poly(ADP-ribose) (PAR) modification of proteins has emerged 
as an important epigenetic regulation of chromatin structure and gene expression.  In 
particular, the PARlation mark was shown to associate preferentially with the maternally 
inherited H19 ICR allele, and this association depended on functional target sites of 
CTCF (Klenova and Ohlsson, 2005).  CTCF itself was found to be PARlated, and the 
maternal Igf2 allele becomes active after 3-aminobenzamide treatment (an inhibitor of 
PAR polymerases), which could be linked to a perturbed chromatin insulator function at 
the H19 ICR. Moreover, more than 150 chromatin insulators associated with CTCF were 
examined in the context of a PARlation mark with evidence that suggests that this mark 
stabilizes CTCF‟s higher-order chromatin conformations (Klenova and Ohlsson, 2005; 
Yu et al., 2004). 
As a final point, MacPherson et al. showed through biochemical assays that CTCF 
can be modified by SUMO (small ubiquitin-like modification) and that this sumoylation  
contributes to the repressive function of CTCF (MacPherson et al., 2009).  We confirmed 
sumoylation of CTCF through in vivo microscopy and have further clarified the role this 
modification plays in CTCF function (refer to Chapters 2-4).  These studies show that 
posttranslational modifications of CTCF play important roles in its regulation of 
epigenetic states.  Moreover, the phosphorylation, PARlation, or sumoylation of CTCF 
suggests a potential switching mechanism to convert CTCF to a specific regulatory 
activity.             
 
SUMMARY OF PROJECT 
Our current understanding of CTCF, insulators, and nuclear architecture has 
advanced dramatically over the last few years.  For example, alternative models for 
insulator activity have drawn from the 3C experiments showing insulators interacting 
with enhancers and promoters and propose that their interactions produce specific loop 
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conformations that allow or block productive promoter/enhancer contact (Kurukuti et al., 
2006; Murrell et al., 2004; Yoon et al., 2007). Furthermore, anchoring chromatin loops 
between nuclear structures and regulatory regions may be an important activity of CTCF 
and its co-factors. Similarly, it is becoming increasingly clear that activators initiate long-
range movements of genes directed to related subnuclear structures such as polymerase 
factories and interchromatin granules (Nunez et al., 2008; Osborne et al., 2007).  For both 
enhancer and insulator proteins, establishing and maintaining long-range chromosomal 
interactions are likely to require the decondensation of chromatin (Chambeyron and 
Bickmore, 2004; Sexton et al., 2007).  Opening chromatin increases its flexibility and 
makes DNA bound factors more accessible, both of which would facilitate contacts 
between distant regulatory regions. Thus, CTCF and other insulator proteins may direct 
chromatin decondensation before anchoring loops or establishing interactions with 
enhancers, promoters, or other insulators.  Notably, not all transcription factors possess 
the ability to recruit the factors necessary to initiate chromatin decondensation (Carpenter 
et al., 2005). 
CTCF‟s necessity for small and large-scale chromatin structure seems well-
established, but its sufficiency to induce changes in chromatin is less clear.  Furthermore, 
despite the multifunctional nature of CTCF, very little has been established towards 
mapping and characterizing domains within CTCF that carry out its functions.  In this 
work, we have used transgene-based assays to address whether CTCF is sufficient to 
initiate chromatin decondensation and, if so, which domains are necessary and which 
transcriptional cofactors it recruits. In chapter 2, we identified CTCF‟s activation domain 
NTAD and showed that the sumoylation site within this domain reduces the potency of 
its transactivation and chromatin opening activities.  In chapter 3, we mapped three 
domains in CTCF‟s NT and CT regions that induce chromatin unfolding of a transgenic 
lac operator array and characterized the proteins recruited by each domain (Carpenter et 
al., 2005; Robinett et al., 1996; Tumbar et al., 1999).  Finally, in chapter four we were 
able to map CTCF‟s enhancer blocking activity to a CT domain and the sumoylation site 
within this domain. 
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FIGURES AND TABLE 
 
Table1.1 Highlight Time Line of CTCF 
1990 “Silencer protein” CTCF is discovered at chicken myc gene and NeP1 at the 
lysozyme gene (Baniahmad et al., 1990; Lobanenkov et al., 1990) 
1997 CTCF is shown to be an activator (Vostrov and Quitschke, 1997) 
1998 CTCF gene deletions linked to cancer (Filippova et al., 1998) 
1999 CTCF linked to enhancer blocking activity at globin insulator (Bell et al., 1999) 
2000 CTCF controls H19/Igf2 imprinted gene expression; methyl-sensitive (Bell and 
Felsenfeld, 2000; Hark et al., 2000; Kanduri et al., 2000; Szabo et al., 2000)  
2002 CTCF linked to X inactivation; CTCF and positioned nucleosomes associated (Chao 
et al., 2002; Kanduri et al., 2002) 
2003 CTCF maintains differential DNA methylation (Pant et al., 2003; Schoenherr et al., 
2003) 
2004 CTCF mediates positioning of interphase chromatin; CTCF directly linked to 
Beckwith-Wiedemann Syndrome (Sparago et al., 2004; Yusufzai and Felsenfeld, 
2004; Yusufzai et al., 2004) 
2005 CTCF found in Drosophila (Moon et al., 2005) 
2006 CTCF and chromatin remodeling protein CHD8;  Long-range inter- and intra-
chromosomal interactions shown (Ishihara et al., 2006; Kurukuti et al., 2006; Ling et 
al., 2006; Splinter et al., 2006; Zhao et al., 2006a; Zhao et al., 2006b) 
2007 CTCF mapped genome-wide, dCTCF associated with Drosophila insulators; 
Required for homologous X-chromosome pairing (Barski et al., 2007; Gerasimova et 
al., 2007; Kim et al., 2007a; Mohan et al., 2007; Xi et al., 2007; Xie et al., 2007) 
2008 CTCF and cohesin interact (Parelho et al., 2008; Rubio et al., 2008; Stedman et al., 
2008; Wendt et al., 2008) 
2009 CTCF and Oct4 work in X-chromosome counting/pairing; CTCF modified by 
sumoylation (Donohoe et al., 2009; MacPherson et al., 2009) 
2010 CTCF mapped for functional properties of  activation and chromatin opening 
domains; CTCF‟s sumoylation linked to enhancer blocking activity (Kitchen and 
Schoenherr, in press; Kitchen et al., submitted) 
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Figure 1.1 Schematic drawing of CTCF protein.  The DNA binding domain (dark grey) is composed of 
11 zinc fingers and is flanked by N-terminal (white) and C-terminal (mid grey) regions.  Published motifs 
(an N-terminal repression domain, CSII phosphorylation sites, and an AT- hook motif) are indicated by 
black lines.  General transcription activity has been associated with the three domains of CTCF. 
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Figure 1.2  Schematic for insulator function.  Insulators or chromatin boundaries have two functional 
properties: an enhancer blocking activity (left diagram) and a chromatin barrier activity (right diagram) 
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Figure 1.3 Model for imprinting control by CTCF at the Igf2/H19 locus.  CTCF binds to the Imprinting 
Control Region (ICR) in a methylation-dependent manner.  On the maternal chromosome, CTCF binding 
prevents downstream enhancers from activating the Igf2 gene.  On the paternal chromosome, the ICR is 
methylated, which prevents CTCF-binding, leading to the repression of H19 and allowing the enhancers to 
activate Igf2. 
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Figure 1.4 Schematic of linked proteins partners to CTCF.  Protein partners are broadly grouped by 
function and are listed (with references to their discovery annotated):  YB1, Y-box protein 1 (Chernukhin et 
al., 2000; Klenova et al., 2004); Yy1, yin and yang 1 (Donohoe et al., 2007); Kaiso (De La Rosa-Velazquez 
et al., 2007; Defossez et al., 2005); CIITA, MHC class II transactivator, and RFX, regulatory factor X 
(Majumder et al., 2006; Majumder et al., 2008); SIN3A (Lutz et al., 2000b); H2A.Z (Barski et al., 2007; 
Guastafierro et al., 2008; Yusufzai et al., 2004); Cohesins (Parelho et al., 2008; Rubio et al., 2008; Stedman 
et al., 2008; Wendt et al., 2008); Taf1/Set (Yusufzai et al., 2004); CHD8, chromodomain helicase DNA-
binding protein 8 (Ishihara et al., 2006); Suz12, suppressor of zeste 12 homolog (Han et al., 2008; Li et al., 
2008); RNAP II, RNA polymerase II (Chernukhin et al., 2007); Lamin A/C (Guelen et al., 2008); Importins 
α1/α3 (Yusufzai et al., 2004); CP190, centrosomal protein 190 (Gerasimova et al., 2007; Mohan et al., 
2007); PARP1 poly(ADP-ribose) polymerase 1 (Caiafa and Zlatanova, 2009; Guastafierro et al., 2008; 
Ogino et al., 2007; Zlatanova and Caiafa, 2009); Nucleophosmin, B23 (Yusufzai et al., 2004); Topo II 
(Yusufzai et al., 2004).   
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CHAPTER 2: CTCF ACTIVATES TRANSCRIPTION AND 
DECONDENSES CHROMATIN 
 
INTRODUCTION 
CTCF is a zinc finger DNA binding protein that was first identified as a 
transcriptional repressor of the c-myc and chicken lysozyme genes (Baniahmad et al., 
1990; Lobanenkov et al., 1990).  More recently, CTCF was shown to repress hTERT and 
PAX6 (Li et al., 2004; Renaud et al., 2007). On the other hand, CTCF activates APP and 
cooperates with CIITA and regulatory factor X to drive expression of two HLA genes 
(Majumder et al., 2008; Vostrov et al., 2002).  CTCF also cooperates with the thyroid 
hormone receptor to both positively and negatively regulate the transcription of several 
genes (Lutz et al., 2003).  CTCF, however, is best known as an insulator protein that 
blocks enhancer activity at Igf2/H19, chicken β-globin, and other loci (Phillips and 
Corces, 2009).  Insulators also prevent the spread of heterochromatin, and loss of CTCF 
binding correlates with the acquisition of repressive epigenetic marks and silencing of c-
myc, DM1, and p16(INK4a) (Cho et al., 2005; Gombert and Krumm, 2009; Witcher and 
Emerson, 2009).  
CTCF also regulates the architecture of the genome (Phillips and Corces, 2009).  
Genome-wide analyses identified thousands of CTCF sites that are associated with 
nuclease sensitivity, increased histone methylation and positioned nucleosomes, 
suggesting that CTCF directs localized remodeling of chromatin (Cuddapah et al., 2009; 
Fu et al., 2008; Xi et al., 2007).  Analyses of individual genes also showed open 
chromatin and higher levels of H3 and H4 acetylation surrounding CTCF sites (Han et 
al., 2008; Litt et al., 2001).  On a larger scale, results from chromosome conformation 
capture (3C) studies indicated that CTCF mediates interactions between distant 
intrachromosomal regulatory regions to form chromatin loops (Splinter et al., 2006; Xu et 
al., 2007; Yoon et al., 2007).  Similar results suggested that CTCF is required for 
interchromosomal interactions between Xist alleles in female cells and between the 
Igf2/H19 and Wsb1/Nf1 loci (Ling et al., 2006; Xu et al., 2007).  
19 
 
CTCF‟s diverse regulatory and structural functions are likely to require multiple 
functional domains throughout the protein. However, specific domains necessary for 
transactivation, enhancer blocking or altering chromatin structure have not been 
identified.  Limited functional mapping localized repression to the zinc finger and C-
terminal regions, and both activation and repression to its N-terminal region (Burcin et 
al., 1997; Filippova et al., 1996; Lutz et al., 2000b; Vostrov et al., 2002).  In addition, a 
more extensive mapping identified a small repression motif in its N-terminal region 
(Drueppel et al., 2004).  In some cases, the transcriptional effects of CTCF and its 
domains varied substantially between cell types, suggesting additional levels of 
regulation (Lutz et al., 2000b).  CTCF is also subject to modification by the small 
ubiquitin-like modifiers 1, 2, and 3 (SUMO) and to ADP-ribosylation, which contribute 
to its repression and enhancer blocking activity, respectively (MacPherson et al., 2009; 
Yu et al., 2004). 
 To better understand how CTCF performs its disparate functions, we mapped 
transcriptionally active portions of the protein and identified an activation domain in its 
N-terminal region that also alters chromatin structure. Detailed characterization of the 
domain indicated that it has moderate activity and limited ability to act over a distance. 
On the other hand, it induced large-scale chromatin decondensation of a lac operator 
array in a manner similar to the highly active VP16.  Finally, we also showed that 
sumoylation of this domain suppressed its transactivation and chromatin opening activity.   
 
RESULTS 
The N-terminal region of CTCF activates transcription 
CTCF has been reported to both activate and repress transcription in transient 
transfection assays (Ohlsson et al., 2001). To determine its transcriptional activity in our 
hands, we constructed plasmids expressing full length murine CTCF fused to the DNA 
binding domain (DBD) of a GFP-tagged Lac repressor (LacR) or a Flag-tagged Gal4.  
Separate reporter plasmids consisted of eight sites for LacR or five for Gal4 just upstream 
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of a minimal TATA box driving a luciferase gene.  Using both LacR and Gal4 DBDs 
reduced the chance that our results would be specific to either fusion partner or reporter 
plasmid. As the array-bearing cells (A03) described below were derived from CHO cells, 
our initial co-transfections were performed in CHO, and we found that both CTCF 
fusions activated their appropriate luciferase reporters in these cells (Fig. 1A).  Since 
transactivation conflicted with previous reports of repression by CTCF, we transfected 
Cos7 and HeLa cells to determine if this result was specific to CHO.  However, amongst 
the three cell lines, we found that LacR-CTCF‟s activation ranged from 6- to 75-fold 
compared to LacR alone and from 1.2- to 14-fold by Gal4-CTCF.  Of the two fusions, 
LacR-CTCF was consistently more active than Gal4-CTCF, and both were most active in 
CHO cells and least active in HeLa cells. Thus, our results from the three cell lines 
suggest that activation, but not repression, of reporter plasmids by CTCF is relatively 
common.  
CTCF consists of a zinc finger DBD (ZF) that is flanked by N-terminal (NT) and 
C-terminal (CT) regions, and we determined which of the three were responsible for 
transactivation.  Using both LacR and Gal4 fusions, transfection assays showed that 
much or all of CTCF‟s transactivation resides in the NT (Fig. 1A).   In CHO cells, LacR-
NT activated the luciferase reporter 21-fold over LacR alone, which was lower than the 
full length CTCF fusion‟s 75-fold induction (Fig. 1A). By contrast, the Gal4-NT fusion 
was at least 10-fold more active than Gal4-CTCF in two cell lines. The activity 
differences between CTCF and its NT could reflect protein interactions specific to the 
full length protein.  In contrast to the NT, both DBD fusions to the CT region generally 
were inactive, although LacR-CT activated the reporter 2.6-fold in CHO cells.  For the 
ZF domain, the LacR fusion showed no significant activation or repression, but Gal4-ZF 
produced 3- to 5-fold repression (Fig. 1A).  For the NT, CT and ZF fusions, Western 
analysis revealed similar levels of expression, and immuno-staining showed all fusions 
localized to the nucleus (Fig. 1B, C and data not shown).  Ours results suggested that 
only the NT region of CTCF activates substantially and that significant differences in 
fusion activity can occur depending on DBD partners and cell types. 
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CTCF’s activation domain is comprised of partially redundant subdomains and an 
inhibitory sequence 
To map CTCF‟s transactivation domain in more detail, we assayed a deletion 
series of the NT region (amino acids 1-270) fused to LacR and Gal4 (Fig. 2A).  Although 
activation levels in the three cell lines and with both DBDs showed quantitative 
differences, overall results were qualitatively consistent.  The one exception was the 
N(183-270) segment, for which the LacR fusion was relatively neutral, while the Gal4 
fusion repressed transcription 3- to 5-fold (Fig. 2A).   
Our initial deletions indicated that most or all of the transactivation activity 
localized to N(44-150), and we mapped this further with a series of N- and C-terminal 
deletions (Fig. 2A).  For the C-terminal deletions, the largest effect came from removing 
N(107-150).  Further deletion of N(85-106) eliminated almost all transactivation, as the 
N(44-65) and N(44-84) fusions activated no more than 2.5-fold in any cell line. For the 
N-terminal deletions, removing N(44-64) caused a decrease in transactivation roughly 
equal to deleting N(107-150), which was unexpected as the N(44-65) segment by itself 
was almost inactive.  Another surprise came from the N(84-150) fusion, which activated 
about 2- to 5-fold more than N(65-150) in all three cell lines.  The increased activity 
suggested that N(65-83) contains an inhibitory motif and that activation by N(44-65) may 
balance the inhibition.  As seen with the C-terminal deletion of this sequence, removing 
N(84-106) produced the largest percentage loss of activity, on average.  Consistent with 
importance of this sequence, N(84-106) by itself averaged almost 5-fold transactivation, 
and deleting it from N(44-150) reduced transactivation about 4-fold.  In contrast, N(44-
65) and N(106-150) were important for the total activity of N(44-150), but both activated 
no more than 2-fold by themselves.  Finally, deleting N(44-150) eliminated 
transactivation by the NT.  Western blots showed similar expression levels of the 
deletions (Fig. 2B, C).  All fusions had an SV40 NLS and were localized to the nucleus 
(data not shown). Thus, CTCF‟s AD, which we have termed the NTAD, maps to N(44-
150) and consists of at least three partially redundant subdomains and a sequence that 
reduces its activity.  
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The NTAD has transcriptional activities intermediate to acidic and glutamine-rich 
activation domains 
To further characterize the NTAD functionally, we determined its activity in 
several assays and compared it to the acidic activation domains (ADs) from VP16 and 
p65 (RelA) and to the glutamine-rich AD from Sp1. In transfections of several cell types 
using both Gal4 and LacR fusions, transcriptional activation by the VP16 and p65 ADs 
ranged from 1000- to 9000-fold when bound immediately adjacent to the minimal TATA 
box, while the Sp1 AD produced 2- to 18-fold activation (Fig. 2A). Thus, the 12- to 60-
fold activation by the NTAD places it closer to the Sp1AD in promoter proximal 
activation.  This pattern continued as Gal4-NTAD and -Sp1AD activated the minimal 
TATA reporter less than 3-fold from a position 3 kb distal and did not show synergistic 
activation with LacR-Sp1AD when it was targeted to promoter proximal sites (Fig. 3A).  
By contrast, the VP16 and p65 ADs activated from about 18- to 70-fold and did synergize 
with the Sp1 AD (Fig. 3A).  Similarly, LacR-NTAD and LacR-Sp1AD did not activate 
more than 3-fold when targeted immediately upstream of or 2 kb downstream of the H19 
promoter (Fig. 3B, C), which has multiple Sp1 binding sites (Szabo et al., 1998).  The 
VP16 and p65 ADs strongly activated the H19 promoter from both positions.  Notably, in 
both distal reporter assays, the full-length CTCF fusions were more active than the 
NTAD, suggesting additional activation domains in CTCF (Fig. 3B, C).  In contrast to its 
activity in mammalian cells, the NTAD was more similar to acidic ADs in S. cerevisiae, 
as Gal4 fusions to full length CTCF, the NTAD and the VP16 AD activated His3, 
whereas the Sp1 AD did not (Fig. 3D).  Overall, the NTAD exhibited transactivation 
properties that were intermediate to those of acidic- and glutamine–rich ADs.  
The NTAD induces histone acetylation and decondenses the chromatin structure of 
a transgene array. 
CTCF sites are frequently associated with open chromatin, histone acetylation, 
and phased nucleosomes (Fu et al., 2008), which suggest that CTCF elicits changes in 
chromatin and histone modifications.  To provide direct evidence that CTCF can alter 
chromatin structure and to address whether the NTAD could contribute to that activity, 
we determined if the NTAD alters the structure of a large, stably integrated tandem array 
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of a plasmid containing 256 lac operators (Fig. 4A). This array is present in the genome 
of a CHO cell derivative, A03, and appears as a condensed, heterochromatin-like 
structure that forms a 2 µm
2
, DAPI-rich „homogeneously staining region‟ (HSR) (Fig. 
4B) (Robinett et al., 1996).  Given its large size, decondensation or “opening” of the HSR 
can be visualized in the fluorescent microscope via GFP-tagged LacR fusions, and in that 
sense, the HSR is analogous to puffs formed by active genes in polytene chromosomes. 
Dramatic opening of the array, however, does not require transcription (Tumbar et al., 
1999).  Moreover, previous studies and our results showed that only certain ADs were 
capable of decondensing the HSR (Carpenter et al., 2005). For example, when bound by 
transiently expressed LacR-VP16AD or -p65AD, the condensed array often opened into 
numerous foci or fibrils that extended through much of the nucleus, which indicated 
substantial unfolding of the array‟s normally condensed chromatin (Fig. 4A, D, E) 
(Tumbar and Belmont, 2001). On the other hand, arrays targeted by LacR fusions to the 
Sp1 AD or the proline-rich CTF AD never appeared larger than ones targeted by LacR 
alone (Fig. 4B and data not shown) (Carpenter et al., 2005). By comparison, many of the 
arrays targeted by the LacR-NTAD resembled those bound by acidic ADs (Fig. 4F).  
Similar results were seen with LacR-CTCF fusions (data not shown). Finally, 
substantially opened arrays lost most or all of the enriched DAPI staining seen with the 
condensed array and were not generally associated with the DAPI-rich portions of the 
nucleus (Fig. 5).  
Overall, the appearance of the HSRs targeted by LacR-NTAD varied from a 
single spot matching the condensed array to structures that spread through roughly a third 
of the nucleus. By eye, the degree of chromatin opening by NTAD appeared similar to 
that of the VP16 and p65 ADs, which was intriguing given that they were roughly 100-
fold more active than the NTAD in the promoter proximal transactivation assays.  In 
contrast, LacR-Sp1AD did not open the array, but activated only 9-fold less than LacR-
NTAD from the proximal position.  To quantify the decondensation activity of the NTAD 
and VP16 AD, we measured the area that the targeted arrays encompassed using a 
computer-controlled microscope that collects digital images of nuclei with targeted arrays 
and determines the number of pixels within the nucleus that have GFP fluorescence 
above a minimum intensity (Carpenter and Belmont, 2004).  After converting the pixel 
24 
 
count into area, we defined as “fully opened” those arrays that encompassed an area 
greater than three standard deviations from the average size of control HSRs targeted by 
the inert LacR (Fig. 4J).  In cells expressing LacR-NTAD, 44% of the targeted HSRs 
fulfilled this criterion, with an average area of 7.3µm
2
 (Fig. 4J). In the remainder of the 
expressing cells, 36% were “partially opened” (between 1 and 3 standard deviations 
greater than the control HSR), and 19% remained “condensed” (within one standard 
deviation.)  For comparison, the highly active LacR-VP16AD fully opened the HSR in 
56% of expressing cells, with a mean area of 7.9µm
2.  To show that the NTAD‟s 
chromatin opening activity was not specific to A03 cells, we also transfected two 
additional CHO lines bearing similar lac operator arrays (D11, G12) (Tumbar et al., 
1999) and found that the NTAD and VP16AD elicited similar levels of decondensation 
(data not shown).  Finally, 85% (34/40 cells) of arrays bound by LacR-NTAD showed 
high levels of staining for hyperacetylated histone H4, while staining was detectable in 
only 5% (2/40 cells) of LacR-bound arrays (Fig. 6).  In comparison, strong staining was 
present at essentially 100% of arrays targeted by LacR-VP16AD (data not shown) 
(Tumbar et al., 1999). Thus, in contrast to its modest transactivation, the NTAD 
demonstrated levels of array decondensation activity and H4 hyperacetylation that were 
similar to a strong acidic AD. 
NTAD subdomains contribute to its chromatin decondensation activity 
The contrast between the NTAD‟s modest transactivation and its strong chromatin 
opening activity suggested that they could be elicited by different portions of the NTAD 
and could reflect interactions with different transcriptional cofactors.  Using the deletion 
series, we found that all of the NTAD segments tested were capable of inducing 
significant HSR decondensation, including ones that showed only 2-fold transactivation 
in the parent CHO cells (Fig. 4J).  Moreover, each of the three main subdomains was 
capable of producing “fully opened” arrays, although at a much lower frequency (Fig. 
4G, H, I, J).  As seen with transactivation, quantifying the area encompassed by the 
targeted arrays showed that the NTAD deletions opened the HSR less than the full 
domain.  In addition, the transcriptionally inactive N(1-48), N(183-270), N(149-186), and 
delta(N44-150) segments of the NT did not open the HSR (Fig. 4J and data not shown). 
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As with transactivation, the entire NTAD contributes to chromatin decondensation.  
However, the substantial opening activity of some subdomains with weak transactivation 
suggests distinct cofactor interaction. 
Sumoylation modulates transactivation and array decondensation by the NTAD  
Our deletion analysis revealed an inhibitory segment within the NTAD that 
reduced its transactivation between 2-5-fold.  We noted that this segment contains the 
sequence 
72
MKTE, which matched the consensus for SUMO modification sites, 
ψKXD/E, where ψ is a bulky hydrophobic residue (Gill, 2005). This motif is recognized 
by the SUMO E2, Ubc9, which ligates Sumo-1, -2, or -3 to the lysine residue in the 
SUMO modification sequence.  After conjugation, SUMO-specific isopeptidases 
complete the cycle by removing SUMO from target proteins.  Sumo-1 shares roughly 
50% identity with Sumo-2 and -3, which are 95% identical and likely to be functionally 
equivalent.  While this work was in progress, MacPherson et al. used biochemical 
techniques to show that lys73 was subject to sumoylation and found that sumoylation 
contributes to CTCF‟s repression of a reporter construct driven by the c-myc promoter 
(MacPherson et al., 2009).  They did not, however, address how sumoylation affects 
transactivation and chromatin decondensation by CTCF‟s NTAD.  
Many transcriptional activators are subject to conjugation by SUMO and, in most 
cases, the modification reduces their transactivation (Gill, 2005). To test if the 
sumoylation motif inhibits NTAD activity, we created NTADR by changing lys73 to 
arginine, which prevents SUMO conjugation.  We found that LacR-NTADR activated 
transcription from 2- to 3-fold more than LacR-NTAD over a range of expression levels 
(Fig. 7A).  In addition, co-expression of the SUMO isopeptidase, Senp1, increased 
activation by the NTAD but not the NTADR.  A catalytically inactive Senp1 mutant had 
no effect on either fusion (Fig. 7B).  Although it showed increased transactivation, the 
mean area of arrays targeted by LacR-NTADR was not significantly larger than those 
bound by LacR-NTAD in transfections of A03 cells (Fig. 7D).  However, we confirmed 
that the NTAD fusion did recruit all three SUMO proteins to the HSR in a lys73-
dependent manner (data not shown).  
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The moderate effect that sumoylation had on transactivation could indicate that a 
sumoylated NTAD is not strongly inhibited by the modification. However, for most 
target proteins, less than 10% of the total pool is sumoylated at any moment, which 
makes it difficult to measure the activity of the sumoylated species (Hay, 2005).  To 
address this difficulty, we created translational fusions of the conjugation-defective 
Sumo-1 or -3 to the C-terminus of the LacR-NTAD and -NTADR to mimic full 
sumoylation (Ross et al., 2002). In contrast to the 2-fold inhibition by the sumoylation 
motif, direct fusion of Sumo-1 and -3 lead to nearly complete inhibition of both NTAD 
and NTADR transactivation (Fig. 7C).  Notably, the NTAD-SUMO fusions were 
transcriptionally neutral, not repressive.  In the decondensation assay, direct fusion of 
Sumo-3 almost completely suppressed the NTADR‟s opening activity to levels similar to 
the LacR control.  Direct fusion of Sumo-1, however, reduced the NTADR‟s mean array 
area by only 18% (Fig. 7D). 
Several corepressors have SUMO interaction motifs (SIMs) and are recruited to 
conjugated proteins via a SIM interaction domain within the three SUMO proteins 
(Ouyang et al., 2009; Song et al., 2004). To test the importance of this domain in our 
assays, we measured transactivation and array opening activity of the LacR-NTADR 
fused to a Sumo-3 with mutations (K32E, K41E) that prevent its interactions with 
corepressors (Chupreta et al., 2005).  In both assays, the mutations nearly or completely 
eliminated Sumo-3‟s inhibitory activity, indicating that the SIM interaction domain was 
necessary for its inhibition of transactivation and chromatin opening (Fig. 7C, D).  In 
contrast, a mutation (D62R) that reduces interaction with the Ubc9 (Knipscheer et al., 
2007) had only a small effect on inhibition by Sumo-3.  Combining the two, however, 
eliminated Sumo-3‟s inhibitory activity in both assays, suggesting that each surface 
contributes to repressing transactivation and decondensation.  
 
DISCUSSION 
CTCF is a multifunctional transcription factor that activates and represses 
transcription, as well as regulates chromatin architecture by mediating chromatin loop 
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formation and positioning nucleosomes.  It also functions as an insulator protein that 
blocks enhancer activity and maintains open chromatin (Ohlsson et al., 2001; Phillips and 
Corces, 2009).  To identify which portions of CTCF have the potential to participate in 
such divergent regulatory modes, we characterized a domain in CTCF‟s N-terminal 
region that activates transcription and alters chromatin structure.  In addition, we found 
that sumoylation of this domain reduced its transactivation and chromatin opening 
activity. 
CTCF is generally thought to regulate transcription by altering small- and large-
scale chromatin architecture, and we initially attempted to delineate CTCF‟s 
transcriptional and chromatin modifying domains in a native chromatin context.  
However, as reported by others, we found that knockdown of CTCF inhibited cell growth 
and over-expression of CTCF either inhibited cell growth or could not be maintained 
(data not shown) (Docquier et al., 2005; Rasko et al., 2001).  Moreover, microarray 
analysis after CTCF knockdown showed gene expression changes of only 2- to 4-fold, 
which would greatly limit the range of measurable effects (Wendt et al., 2008).  Taken 
together, these difficulties prevented us from reliably replacing CTCF with deletion 
mutants and made analysis of its functional domains using endogenous genes technically 
impractical.  Therefore, we chose to map functional domains using both transient reporter 
assays and the lac operator array.  Transcriptional domains of many transcription factors 
have been determined using transfected reporters, and the lac operator array provides an 
assay for changes in native chromatin structure that is independent of transcription 
(Tumbar et al., 1999). 
In transient assays, we showed that full length CTCF generally activated 
transcription when fused to two different heterologous DBDs.  Further analysis localized 
most or all transactivation to 107 amino acids in the center of the N-terminal region, 
while the CT and ZF regions showed minimal or no activation.  The location of the 
NTAD is consistent with results that mapped transactivation to the NT using in vitro 
transcription in nuclear extracts (Vostrov et al., 2002). On the other hand, several other 
studies showed that full length CTCF and NT fusion proteins repressed transcription in 
transfection assays (Drueppel et al., 2004; Filippova et al., 1996; Lutz et al., 2000b).   In 
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contrast, we never saw repression by CTCF or its NT.  Within the NT, however, the 
N(180-270) segment was repressive but only as a Gal4 fusion, not LacR.  Similarly, the 
ZF region was a repressor only when fused to Gal4. Repression by these two domains 
agrees with results from Drueppel et al. and Lutz et al., respectively, but its dependence 
on the Gal4 DBD in our experiments makes definitive conclusions difficult (Drueppel et 
al., 2004; Lutz et al., 2000b).  Previous studies also found strong repression mediated by 
the CT, whereas in our hands, it was either neutral or activated slightly (Filippova et al., 
1996; Lutz et al., 2000b). The sources of these discrepancies are unknown, but our results 
suggest that the fusion partner and cell type have substantial influence on CTCF‟s 
activity in transfection assays.  
More than 10,000 CTCF sites have been indentified across the genome and, as 
expected for an insulator protein, about 55% are located in intergenic regions.  However, 
about 10% are in promoters and 35% in genes (Cuddapah et al., 2009).  To better 
understand how CTCF might regulate transcription from different genomic positions, we 
further characterized the NTAD‟s transcriptional activities and compared them to ADs 
from enhancer and promoter factors. When targeted to promoter-proximal positions, the 
NTAD demonstrated moderate activity that was substantially less than that of the acidic 
VP16 and RelA ADs, but several fold more than the glutamine-rich Sp1 AD. Like the 
Sp1 AD, however, the NTAD demonstrated weak transactivation of a natural promoter 
and from a distance of 2-3 kb. The NTAD‟s intermediate activity suggests that in terms 
of transactivation it is distinct from both enhancer and promoter factors and that it 
directly contributes to gene activation only when bound to more promoter proximal 
positions. 
Transcription factor ADs are often grouped into categories based on their amino 
acid composition (Triezenberg et al., 1995), and the ADs of a given category frequently 
share functional properties in different transcriptional assays (Blau et al., 1996; 
Triezenberg, 1995).  The NTAD is enriched in acidic and hydrophobic residues (19% 
DE; 33% ILMV), as well as the polar residues, glutamine/asparagine (14%).  The 
abundance of acidic and hydrophobic residues resembles acidic ADs, although the NTAD 
is devoid of aromatic residues that acidic ADs often rely on for their potent 
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transactivation (Triezenberg, 1995).  Similarly, the NTAD lacks glutamine clusters that 
characterize glutamine-rich ADs (Triezenberg, 1995).  Thus, as with its intermediate 
transcriptional activity, the NTAD‟s amino acid composition appears between both acidic 
and glutamine-rich ADs. 
In contrast to its modest transcriptional activity, the average array decondensation 
by the NTAD was only about 13% less than the transcriptionally potent AD from VP16 
(Fig. 4J) and greater than that of the p65 AD (NSK, unpublished).  In contrast, the Sp1 
AD had no array opening activity.  The NTAD and VP16 AD also elicited H4 
hyperacetylation of the array to similar degrees. These results suggest that the NTAD has 
chromatin modifying activity comparable to strong transcriptional activators and are 
consistent with those showing that CTCF binding at many endogenous genes is 
associated with open chromatin and modified histones (Fu et al., 2008). Therefore, we 
speculate that the NTAD participates in some of CTCF‟s architectural roles by recruiting 
chromatin opening and histone modifying proteins.  Moreover, while it appears to 
maintain open chromatin, CTCF is not generally thought of as an activator (Phillips and 
Corces, 2009).  Thus, the NTAD‟s limited transactivation would allow CTCF to alter 
chromatin structure without necessarily activating transcription.  Finally, the NTAD‟s 
properties of limited transactivation, strong chromatin opening, and induction of active 
histone marks fit well with some models in which insulator proteins are considered to be 
transcriptionally neutral and block heterochromatin by decondensing chromatin and/or 
modifying histones (Gaszner and Felsenfeld, 2006). Other models for insulator activity 
stress the formation of isolated chromatin loops, and the NTAD‟s ability to open 
chromatin could facilitate interactions between distant insulators necessary for 
establishing these loops.  
Several groups have shown that decondensation of the lac operator array in A03 
cells does not require transcription (Carpenter et al., 2004; Tumbar et al., 1999; Ye et al., 
2001).  This distinction creates the possibility that separable portions of the 107aa NTAD 
mediated its transactivation and array decondensation activity.  Using deletion analysis, 
we found that most subdomains had both activities, but several of them demonstrated 
quantitative differences between their level of transactivation and HSR decondensation.  
For example, N(84-150) transactivated 10-fold more than N(106-150), but its average 
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array area was only 25% higher.  Conversely, some subdomains activated transcription 
no more than 2-fold, but often elicited substantial array decondensation.  The general 
overlap of transactivation and HSR opening activity suggests that each subdomain 
contributes to both processes, while the quantitative differences in activity could reflect 
disparity in the strength of their interactions with certain cofactors.   
Although consistent with CTCF‟s activation and barrier functions, the presence of 
an AD seemed counterintuitive in a protein that also has enhancer blocking and 
repression activities. However, some transcription factors are known to have positive and 
negative regulatory states and to switch between them upon post-translational 
modification.  For example, the zinc finger protein, Sp3, becomes a repressor only when 
sumoylated (Stielow et al., 2008). Similarly, CTCF was shown to be sumoylated on its N- 
and C-terminal regions, and the modification increased its repression of a c-myc reporter 
(MacPherson et al., 2009).  Our results, however, showed that the N-terminal SUMO 
modification site is within an activation domain, and the modification reduced but did not 
eliminate its transactivation.  Moreover, while directly fusing SUMO to the NTAD nearly 
eliminated transactivation, it did not lead to transcriptional repression. We also found that 
full length CTCF fused to SUMO did not repress transcription (data not shown).  Thus, 
our results extend those of MacPherson et al. by putting sumoylation in the context of the 
NTAD, and suggest that sumoylation suppresses its transactivation, but does not 
necessarily convert CTCF into a repressor.   
In addition to its transcriptional effects, we found that translational fusions of 
SUMO-3, but not SUMO-1, lead to a nearly complete loss of array decondensation by the 
NTAD.  These results suggest that CTCF constitutively modified by Sumo-3 is unable to 
open chromatin and provide one of the few examples of activities that distinguish Sumo-
3 from SUMO-1 (Ouyang et al., 2009a).  Moreover, the prevention of array opening by 
Sumo-3 and its dependence on the SIM interaction domain is consistent with Sumo-3‟s 
exclusive interaction with the CoRest/LSD1/HDAC corepressor complex (Ouyang et al., 
2009a).  Given SUMO‟s suppression of transactivation and chromatin opening, we 
speculate that CTCF molecules bound to sites requiring enhancer blocking or repressor 
activity are more often sumoylated than those requiring barrier or activator activity.  
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Notably, less than 10% of CTCF is sumoylated (MacPherson et al., 2009), and it will be 
interesting to determine if this pool represents CTCF molecules bound to loci requiring 
its enhancer blocking or repression functions. 
 
METHODS 
Plasmid constructs 
The pLacR expression plasmid was constructed by modifying p3‟SS-EGFP-dimer 
to include an SV40 NLS and a unique SpeI site at the C-terminus of the enhanced green 
fluorescent protein (EGFP) tagged-dimer lac repressor DNA-binding domain (Tumbar et 
al., 1999).  To construct the empty expression vector, p3‟SS, the GFP-LacR sequences 
were removed by digesting pLacR with XbaI and SpeI and religating.  The pGal4 
expression plasmid was constructed by modifying pcDNA3.1 to include 3 copies of the 
FLAG epitope, the SV40 NLS, and the Gal4 DBD followed by a unique XbaI site. 
Mammalian expression plasmids for hemagglutinin-tagged human Sumo-1, -2, and -3 
and FLAG-tagged human SenP1 and mutant SenP1(C603S) were gifts of R.T. Hay. 
The full-length murine CTCF cDNA was flanked with XbaI sites and inserted into 
the SpeI site of pLacR and the XbaI site of pGal4 to form pLacR-CTCF and pGal4-
CTCF, respectively.   All CTCF deletions were derived from PCR products amplified 
using primers ending in XbaI or SpeI sites.  After digestion, the PCR products were 
inserted into pLacR and pGal4 to create in-frame fusions. The activation domains (AD) 
of VP16 (amino acid residues 369-490), RelA (residues 286-519), and Sp1 (residues 100-
313) were amplified and inserted into pLacR and pGal4 in a similar manner. Point 
mutations in CTCF fragments or Sumo-3 were generated by overlapping PCR.   Sumo-1 
and -3 cDNAs without the C-terminal glycine residues were amplified, digested with 
NheI and XbaI and ligated in frame with the NTAD (residues 44-150 of CTCF) in 
pLacR- and pGal4-NTAD. All PCR-derived constructs were sequenced to ensure fidelity.  
For the LacR constructs, protein expression was confirmed through Western-blot analysis 
of whole-cell lysates using anti-GFP (Upstate Biotech., ms-1315) at 1:4000. For the Gal4 
constructs, anti-FLAG M2 (Stratagene) was used at 1:6000.  For expression in yeast, full 
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length CTCF, the NTAD, VP16 AD, and Sp1 AD were inserted into the NheI site of a 
modified pGBKT7 (Clontech). 
The p5G-Luc reporter contains five Gal4 binding sequences adjacent to an E1b-
TATA driven luciferase reporter.  The p8L-Luc reporter contains eight lac operators 
adjacent to an E1b-TATA driven luciferase reporter (a gift from A. Belmont). To 
construct pH19-Luc, an EcoRV-SmaI fragment containing the murine H19 promoter (-
250 to +17bp) was inserted into SmaI digested pGL3-Basic (Promega). To construct 
p5G-H19-Luc, five Gal4 UAS‟s were inserted into the NheI site of pH19-Luc, which is 
just upstream of the H19 promoter.  In pH19-Luc-8L, eight lac operators were placed 2 
kb downstream of luciferase by inserting a SalI-XhoI fragment from p8L-Luc into the 
SalI site of pH19-Luc.  To construct p8L-Luc-5G, an XbaI-PstI fragment containing the 
five Gal4 sites from p5G-Luc was inserted into p8L-Luc-NN digested with NheI-NsiI.  
To construct p8L-Luc-NN, a NheI-NsiI linker was inserted into the AatII site of p8L-Luc, 
which is 3 kb downstream of luciferase. 
Tissue culture, transient transfections and luciferase assays 
Chinese hamster ovary cells (CHO) were cultured in F-12 Ham‟s medium with 
10% fetal bovine serum (FBS) and COS7 and HeLa cells in DMEM 10% FBS.  A03 cells 
were cultured in F-12 Ham‟s medium without hypoxanthine and thymidine, 10% 
dialyzed FBS, and 0.3µM methotrexate. All cells were incubated at 37°C in 5% CO2.   
Transient transfections of A03 cells were performed on coverslips in 35mm plates 
with 1 µg of the pLacR fusions and 4 µl of Mirus TransIT-LT1. Transient transfections of 
CHO, HeLa, and COS7 cells were performed in 6-well plates for 48 hours. Cells were 
harvested in lysis buffer (1% triton, 50 mM Tris base, 25 mM phosphoric acid, 1 mM 
EDTA) and assayed in luciferase reaction buffer (400mM Tris base, 200 mM phosphoric 
acid, 1mg/mL BSA, 5 mM DTT, 0.3 mM D-Luciferin, 3 mM ATP, 5 mM MgCl2).  
Luciferase and β-galactosidase activity (CPRG) were measured using a Tecan ULTRA 
Evolution plate reader.     
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Immunocytochemistry 
Forty-eight hours after initiating transfection, coverslips containing A03 cells 
were rinsed twice in PBS-ME (Dulbecco‟s phosphate buffered saline without Ca+2 and 
Mg
+2
, 5 mM MgCl2, 0.1 mM EDTA), permeabilized for 60 sec in PBS-MET (PBS-ME, 
0.1% Triton X-100), fixed in 1.8% formaldehyde in PBS-ME for 15 min at room 
temperature, and then quenched with three 5 min washes of PBS-ME with 20mM 
glycine. The coverslips then were blocked at 4ºC in PBS+5% normal goat serum for 60 
min, washed three times for 5 min each in PBS-MET and incubated at 4°C for 24 h with 
primary antibody diluted in PBS-MET at 1:500 for rabbit anti-acetylated tail H4 (Serotec 
AH418).  After primary antibody incubation, coverslips were washed three times in PBS-
MET and then incubated at 4°C overnight with Texas Red goat anti-rabbit IgG (Jackson 
ImmunoResearch) diluted 1:1000 in PBS-MET.  Coverslips were then washed three 
times with PBS-MET and stained with 0.2 µg/mL 4‟, 6-diamidino-2-phenylindole 
dihydrochloride (DAPI) for 5 min, followed by two PBS-ME rinses.  Coverslips were 
mounted onto slides with a Mowiol-DABCO antifade reagent.  For determining co-
localization at the HSR, coverslips from at least three separate transfections were stained 
and 40 nuclei showing co-expression were scored. 
Imaging and image analysis 
Light microscopy images were taken in the DAPI, fluorescein, and Texas red 
channels on an inverted light microscope equipped with a cooled, slow-scan charge-
coupled device camera (IMT-2; Olympus or Applied Precision OMX V2 with 
DeltaVision).  Raw images were deconvolved as described (Robinett et al., 1996) or with 
softWoRx Suite (Applied Precision).  Representative optical sections were processed 
using ImageJ.  For quantifying HSR areas, a computer-controlled microscopy system 
collected images of the nuclei of transfected A03 cells in both the fluorescein and DAPI 
channels, as described (Carpenter and Belmont, 2004).  The program only collected 
images of GFP fluorescence that was associated with a DAPI-stained nucleus and was 
above a minimum intensity to exclude cells expressing low levels of the GFP-LacR 
fusions.  After image collection, cells with a high level of GFP fluorescence throughout 
the nucleus were manually excluded, as this condition prevented accurate localization of 
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the targeted HSR. The program then determined the number of pixels within the nucleus 
that were above a threshold of GFP signal.  For each fusion, the area of the HSR was 
determined in 50 to 150 nuclei in each of two independent transfections.  To calculate p 
values, Student‟s t-tests with unequal variance and a set to 0.025 were performed using 
Microsoft Excel‟s Analysis ToolPak. 
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FIGURES 
 
 
Figure 2.1 The N-terminal region of CTCF activates transcription. (A) Relative luciferase expression 
from CHO, Cos7, and HeLa cells transfected with the p8L-Luc reporter and LacR fusion plasmids or the 
p5G-Luc reporter and Gal4 fusion plasmids. The illustrations indicate the LacR or Gal4 fusion partners 
(DBD) and CTCF‟s N-terminal region (NT, residues 1-270), the zinc-finger DNA-binding domain (ZFs, 
residues 248-611), and the C-terminal region (CT, residues 575-736).  The amino acid residues are 
indicated below each construct. Normalized luciferase expression is relative to the control pLacR or pGal4 
plasmids, taken as 1.  The mean and standard deviation (SD) were derived from at least three independent 
experiments.  (B-C) Western analysis showing normalized protein expression of the LacR (B) and Gal4 (C) 
fusions after transfection in CHO cells. Similar results were seen in HeLa and Cos7 cells. 
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Figure 2.2  CTCF’s activation domain comprises three subdomains and one inhibitory sequence. (A) 
Relative luciferase expression from CHO, Cos7, and HeLa cells transfected with the p8L-Luc reporter and 
LacR fusion plasmids or the p5G-Luc reporter and Gal4 fusion plasmids. The schematic illustrates the 
portions of the NT and other activation domains (AD) fused to the LacR and Gal4 DBDs. The amino acid 
residues are indicated below each construct.  Normalized luciferase expression is relative to the control 
pLacR or pGal4 plasmids, taken as 1.  The mean and SD were derived from at least three independent 
experiments.  Luciferase activity of Gal4-VP16AD was not normalized to β-galactosidase expression due 
to apparent squelching of pSV-βgal. ND, not determined. (B) Western-blot analysis showing the 
normalized protein expression of the LacR (B) and Gal4 (C) NT fusions after transfection in CHO cells. 
Similar results were seen in HeLa and Cos7 cells. The numbers refer to the constructs shown in A. 
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Figure 2.3  Distal transactivation by the NTAD.  (A) Relative luciferase units (RLU) from CHO cells co-
transfected with the indicated Gal4 fusion plasmids (0.5 µg), along with p8L-Luc-5G (diagram; 0.5 µg) and 
either pLacR (0.2 µg; dark gray) or pLacR-Sp1AD (0.2 µg; light gray). All transfections included pSV-β-
Gal (0.1 µg). Normalized luciferase expression is relative to the control pLacR or pLacR-Sp1AD plasmids, 
taken as 1. Error bars indicate SD of at least three independent experiments. (B) Logarithm of relative 
luciferase units from CHO cells co-transfected with p5G-H19-Luc (diagram; 0.5 µg) and Gal4 fusion 
plasmids (0.5 µg). (C) Relative luciferase expression from CHO cells co-transfected with the pH19-Luc-8L 
reporter (diagram; 0.5 µg) and LacR fusion plasmids (0.5 µg).  (D) NTAD activates transcription of the 
Gal4-UAS driven His3 in yeast. A five-fold dilution series of S. cerevisiae (strain AH109, Clontech) 
expressing the indicated Gal4 fusion proteins were spotted on to minimal media with and without histidine 
(His) and incubated for three days at 30°C. 
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Figure 2.4 The NTAD decondenses the chromatin structure of a lac operator transgene array. (A) 
Illustration of the “homogenously staining region” (HSR), a condensed chromatin structure comprising co-
amplified concatamers of a vector with 256 direct lac operator repeats and hamster genomic DNA.  (B-I) 
Examples of „fully opened‟ arrays in A03 cells transfected with plasmids expressing the indicated LacR 
fusions.  Images are deconvolved optical sections with the left panel showing DAPI (blue) merged with 
GFP signal (green).  The right panel is an enlarged gray-scale image of the HSR. Scale bars, 1 µm.  (J) Box 
plots describing the range of HSR areas when targeted by LacR fusions.  The end lines of the plot indicate 
the 10
th
 and 90
th
 percentiles; the box ends, the 25
th
 and 75
th
 percentiles; and the centerline, the 50
th
 
percentile. The table below the box plots reports the % of „fully opened‟ arrays, the mean area of the HSRs 
(µm
2
), the p-values for t-tests of the mean area compared to GFP-LacR alone, and the total number (n) of 
analyzed nuclei. Amino acid residues are indicated in parentheses. Arrays defined as „fully opened‟ had an 
area >5.67 µm
2
 (495 pixels), which is three standard deviations from the mean area of control GFP-LacR 
targeted HSRs (1.89 µm
2 
±1.26 µm
2
).  
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Figure 2.5  Arrays opened by the NTAD and its subdomains are not associated with DAPI-rich 
portions of the nucleus.  Images are deconvolved optical sections of A03 cells targeted by LacR fusions to 
the indicated sequences with the left panel showing DAPI (blue), the middle is GFP signal (green), and the 
left is the merge. Scale bar, 1 µm. 
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Figure 2.6 The NTAD induces H4 hyperacetylation of a lac operator transgene array. (A, B) Optical 
sections of nuclei from A03 cells transfected with pLacR (A) or pLacR-NTAD (B).  The left panels show 
the GFP-tagged LacR or LacR-NTAD, the second show staining for hyperacetylated histone H4, the third 
show the merge.  The last panel is an enlargement of the merge. 
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Figure 2.7 Sumoylation modulates transactivation and array decondensation by the NTAD.  (A) 
Relative luciferase activity from CHO cells transfected with p8L-Luc (0.5 µg) and the indicated amounts of 
pLacR-NTAD (dark gray) or pLacR-NTADR (light gray).  Empty expression plasmid (p3‟SS) was added 
to bring total plasmid to 1.1 µg in each transfection.  All transfections included pSV-βgal (0.1 µg).  Error 
bars indicate SD of at least three independent experiments. (B) Relative luciferase activity from CHO cells 
co-transfected with p5G-Luc (0.5 µg) and pGal-NTAD (0.2 µg; dark gray) or pGal-NTADR (0.2 µg; light 
gray) in the presence of 0.5 µg of pcDNA3 (Control), pcDNA3-SenP1(C603S) (SenP1M), or pcDNA3-
SenP1 (SenP1).  (C) Relative luciferase expression in CHO cells co-transfected with p8L-Luc and plasmids 
expressing LacR-NTAD (0.5 µg; dark gray) or LacR-NTADR (0.5 µg; light gray) as translational fusions 
to conjugation-defective Sumo-1 (S1), Sumo-3 (S3), Sumo-3(D62R) (S3-U), Sumo-3(K32E, K41E) (S3-S) 
or Sumo-3(K32E, K41E, D62R) (S3-US). (A-C) Western analysis with an antibody against GFP (A, C) or 
the Flag epitope (B) shows normalized protein expression levels. (D) Box plots of HSR areas when targeted 
by NTAD or NTADR and its translational fusions to Sumo-1, Sumo-3 or Sumo-3 mutants.  The table 
below the box plots reports the % of „fully opened‟ arrays, the mean area of the HSRs in pixels, the p-
values for t-tests of the mean area compared to GFP-LacR alone (p-1) and LacR-NTADR (p-2), and the 
total number (n) of analyzed nuclei.  
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CHAPTER 3: MULTIPLE DOMAINS IN CTCF DIRECT 
LARGE-SCALE CHANGES IN CHROMATIN 
STRUCTURE 
 
INTRODUCTION 
The zinc finger transcription factor CTCF is an important regulator of 
chromosomal architecture that also has transcriptional activation, repression, and 
insulator activity (Ohlsson et al., 2001; Phillips and Corces, 2009). Originally identified 
as a negative regulator of c-myc (Lobanenkov et al., 1990), CTCF was later shown to 
provide the enhancer blocking activity of the HS4 insulator from the chicken β-globin 
gene (Bell et al., 1999).  Recently, chromosome conformation capture (3C) studies have 
indicated that CTCF mediates long-range interactions with itself and promoters.  At the 
mouse β-globin locus, the globin promoters and a CTCF-bound portion of the LCR 
interact with multiple CTCF sites located up to 85 kb away (Palstra et al., 2003; Splinter 
et al., 2006). At the Igf2/H19 locus, the CTCF-dependent insulator interacts with the 
promoters of the silent Igf2 gene, which are about 100kb from the CTCF sites (Kurukuti 
et al., 2006; Murrell et al., 2004; Yoon et al., 2007).  CTCF binding is also required to 
maintain expression of c-myc and to form long-range interactions involved in activating 
two HLA genes (Gombert and Krumm, 2009; Majumder et al., 2008).  In addition to cis 
interactions, CTCF is required for trans pairing between the two Xist alleles and between 
the Igf2/H19 and Wsb1/Nf1 loci on chromosomes 7 and 11 (Ling et al., 2006; Xu et al., 
2007).  
It has been proposed that CTCF performs some of its structural functions by 
tethering different chromosomal regions to each other or to nuclear sub-structures 
(Phillips and Corces, 2009; Wallace and Felsenfeld, 2007). Consistent with this idea, 
CTCF interacts with the nucleolar protein nucleophosmin and with the nuclear matrix, 
both of which could act as anchoring sites for chromatin loops (Yusufzai and Felsenfeld, 
2004; Yusufzai et al., 2004). Moreover, many CTCF sites co-localize with the cohesin 
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complex, which is thought to contribute to tethering activity by forming a ring around 
distant chromosomal regions (Parelho et al., 2008; Stedman et al., 2008; Wendt et al., 
2008). Support for this idea comes from recent evidence showing that cohesin is 
necessary for long-range interactions and enhancer blocking at the Igf2/H19 locus 
(Nativio et al., 2009).  
In addition to tethering activity, correlative evidence also suggests that CTCF 
initiates chromatin decondensation and nucleosome remodeling.  Analysis of genome-
wide chromatin immunoprecipitation (ChIP) data showed that most CTCF sites are 
nuclease hypersensitive and that the nucleosomes surrounding them are positioned (Fu et 
al., 2008).   Moreover, histones adjacent to CTCF sites are enriched in modifications that 
are generally associated with open chromatin, and mutating CTCF sites results in 
decreased „active‟ histone modifications and increased DNA methylation (Filippova et 
al., 2005; Han et al., 2008; Schoenherr et al., 2003; Splinter et al., 2006; Verona et al., 
2008). Finally, CTCF appears to functionally interact with the chromatin remodeling 
proteins, Chd8 and Atrx, which suggests that it could recruit these factors to decondense 
or remodel chromatin (Ishihara et al., 2006; Kernohan et al.). 
The correlation of CTCF binding with altered small- and large-scale chromatin 
structure is well-established, but whether it is sufficient to induce changes in chromatin is 
less clear.  To address whether CTCF can initiate chromatin decondensation, we used a 
large, stably integrated transgene array that undergoes visible decondensation when 
bound by certain transcriptional regulators (Carpenter et al., 2005; Tumbar et al., 1999; 
Ye et al., 2001).  With this system, we found that three domains within CTCF can induce 
dramatic decondensation of the array‟s chromatin structure and that each recruits a 
distinct set of transcriptional regulators.  In addition, a domain that activates transcription 
and opens chromatin also recruits the cohesin complex, which links an activation domain 
to cohesin activity for the first time.  Finally, we show that the AT-hook motif in CTCF 
alters the large-scale structure of the array, in a manner that suggests it could serve as a 
tethering domain. 
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RESULTS 
CTCF induces large-scale chromatin decondensation of lac operator transgenic 
arrays.  
To determine if CTCF is sufficient to initiate decondensation of chromatin, we 
employed a cell line (A03) with a stably integrated lac operator array of sufficient size 
that large-scale changes in its chromatin conformation can be observed using light 
microscopy. The lac operator array in A03 cells normally forms a condensed, 2μm2 
„homogeneously staining region‟ (HSR), which is comprised of many repeating units of a 
concatamerized transgene and a large segment (0.5-1Mb) of hamster genomic DNA (Fig. 
1A).  The transgene vector contains 256 copies of the lac operator, which allows protein 
fusions to the lac repressor DNA binding domain (LacR) to specifically target the HSR 
(Fig. 1B). When bound by certain activation domains fused to a GFP-tagged LacR, the 
condensed array exhibits a dramatic „unfolding‟ or „opening‟ of its chromatin that often 
appears as punctate or fibrillar fluorescent signal distributed through a portion of the 
nucleus (Fig. 2A) (Tumbar and Belmont, 2001). Unfolding of the array, however, does 
not require transcription (Tumbar and Belmont, 2001), but most likely depends on the 
recruitment of chromatin remodeling or histone modifying proteins (Johnson et al., 
2008). The ease of detecting large-scale changes in chromatin folding in the absence of 
transcription makes the HSR an excellent reporter for the activity of insulator and 
architectural proteins, as they are likely to alter chromatin structure in the absence of 
enhancer or promoter factors.  
A03 cells were transiently transfected with an expression vector encoding a GFP-
LacR fusion to the full-length mouse CTCF cDNA (LacR-CTCF; Fig. 1B).  In parallel, 
control transfections were performed with a vector encoding GFP-LacR (LacR).  As 
previously reported, the HSR targeted by LacR appeared as a single irregularly shaped 
focus about 1μm in diameter (data not shown) (Robinett et al., 1996).  In contrast, 
targeting of the CTCF fusion to the HSR often resulted in GFP fluorescence dispersed 
through a large portion of the nucleus, which indicates substantial opening of the array‟s 
normally condensed chromatin (Fig. 2B, C). Overall, the CTCF-targeted HSRs ranged in 
size from ones similar to the condensed array to structures that spread through more than 
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a third of the nucleus. To show that CTCF‟s chromatin opening activity was not specific 
to A03 cells, we also transfected two additional CHO lines with similar lac operator 
arrays (D11, G12) and found comparable levels of decondensation (data not shown) 
(Tumbar et al., 1999).  
CTCF‟s ability to unfold the condensed HSR was striking, and although there was 
substantial variation from cell to cell, we recognized two morphologically distinct 
elements to the structure of CTCF-opened HSRs. Among some of the more highly 
opened HSRs, their predominant structural characteristic was the presence of many 
distinct fluorescent foci that were dispersed through a section of the nucleus and often 
connected by fibers of lower intensity GFP signal (Fig. 2B and 3B). In other cells, highly 
opened CTCF-targeted HSRs were characterized by broad regions of comparatively 
homogeneous or contiguous GFP fluorescence, which often had thin fibers of signal 
extending out from them (Fig. 2C and 3D). Thus, CTCF is sufficient to direct chromatin 
decondensation within transgene arrays, and the two structural elements suggest that it 
might use more than one chromatin decondensation or opening pathway. 
To better compare CTCF with other proteins that open the HSR, we quantified the 
extent of array decondensation using an automated microscopy system that measures the 
area encompassed by targeted HSRs (Carpenter et al., 2004). This system directs the 
microscope to obtain images of GFP fluorescence within nuclei and then determines the 
number of pixels with GFP signal above a minimum intensity. Using the pixel count to 
determine the area of targeted arrays, we then defined “fully opened” arrays as those with 
an area greater than 5.7μm2, which is three standard deviations from the average size of 
LacR targeted HSRs (2.1 µm2 ±1.2 µm).  In cells expressing LacR-CTCF, 41% of the 
targeted HSRs fulfilled this criterion, with an average area of 7.0 µm2 (Fig. 2G). In the 
remainder of the expressing cells, 26% were “partially opened” (between 1 and 3 
standard deviations greater than the control HSR), and 33% remained “condensed” 
(within one standard deviation). Both the average size of opened arrays and the percent of 
arrays that open serve as indicators of CTCF‟s array opening activity. 
We then compared CTCF opening activity to the potent activation domain of 
VP16, which was found to induce the most HSR opening amongst several activation 
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domains (Carpenter et al., 2005).  In our experiments, 62% of cells expressing LacR-
VP16 had fully opened HSRs (mean area of 8.5 µm2), and 38% were divided evenly 
between partially opened and condensed. Although the average size of all CTCF-targeted 
arrays was smaller than those bound by VP16, the upper range of CTCF-opened arrays 
was comparable to VP16‟s (Fig. 2G).  Moreover, if only fully opened arrays were 
considered, then the mean areas became 12.1 µm2 (CTCF) and 12.0 µm2 (VP16). These 
results show that an insulator protein can induce changes to the large-scale chromatin 
structure of a transgene array much like a strong transactivator such as VP16.  
The N- and C-terminal regions of CTCF have distinct array decondensation 
activity.  
The two structural elements we noted within CTCF-opened HSRs suggested that 
it might have multiple independent chromatin opening domains.  To determine which 
portions of CTCF were responsible for the distinct structures, we expressed GFP-LacR 
fusions of CTCF‟s N-terminal (NT), zinc finger (ZF), and C-terminal (CT) regions (Fig. 
1B) in A03 cells and compared the morphology of the HSRs targeted by the different 
fusions. We found that both LacR-NT and –CT efficiently induced array opening (Fig. 
2D, F). The ZF region, however, never induced decondensation, and its arrays appeared 
indistinguishable from the LacR control (Fig. 2E).  The larger HSRs opened by LacR-NT 
typically consisted of many dispersed foci, but lacked the broad regions of fluorescence 
exhibited by some CTCF-bound arrays (compare Fig. 2D to 2B, C and Fig. 3A to 3B).  
Indeed, the NT-opened arrays more closely resembled those targeted by LacR-VP16, 
although they were smaller on average and had more fiber-like signal connecting the 
fluorescent foci (compare Fig. 2D to 2A).  By contrast, CT-targeted HSRs were clearly 
morphologically distinct from the punctate NT- and VP16-targeted HSRs, and typically 
consisted of a few elongated bands of contiguous GFP signal with smaller, branched 
extensions (Fig. 2F and Fig. 3C). The long bands of fluorescence, however, were shared 
by a subset of HSRs opened by full length CTCF (compare Figure 2F to 2C and Fig. 3C 
to 3D). 
To provide a more objective metric of array morphology, we assessed the overall 
„connectedness‟ within arrays by determining the longest path of continuous GFP 
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fluorescence present in a single optical section of targeted HSRs and plotted the path 
lengths against array area (Fig. 3E).  Using this metric, we found that the CT-bound 
arrays had the longest continuous paths.  In addition, CTCF‟s were surprisingly similar to 
its CT region, and the path lengths for both fusions grew in parallel with the total array 
size. Consistent with their foci-rich morphology, path lengths for NT- and VP16-bound 
arrays were much shorter than CT‟s on average and increased much more slowly or not at 
all with array size.  These results are consistent with the qualitative differences we 
observed between NT- and CT- targeted arrays. 
After comparing the morphology of the fusion-bound arrays, we quantified their 
array opening activity using the automated microscopy system.  In LacR-NT expressing 
cells, 35% of the HSRs were fully opened (mean area of 6.8 µm2), and an equal number 
were partially opened or condensed (Fig. 2G). For the LacR-CT fusion, 36% of the bound 
HSRs were fully opened (mean area of 6.9 µm2) and 33% remained condensed (Fig. 2G). 
For both NT and CT fusions, the means and the ranges of array sizes were comparable to 
full length CTCF and VP16.  The quantitative analysis showed that CTCF‟s N- and C-
terminal regions are highly active and can open chromatin independently. Moreover, the 
distinct morphologies of their targeted HSRs suggested that the two regions use at least 
one different cofactor to modify chromatin structure. 
CTCF’s C-terminal region has two chromatin opening domains  
The NT and CT regions of CTCF elicited distinct changes in the HSR‟s chromatin 
structure, and we wanted to identify the domains responsible for each activity.  In the 
previous chapter, we performed an extensive deletion analysis of the NT region that 
localized all of the HSR opening activity to the NTAD (amino acids 44-150) and showed 
that it is composed of at least three partially redundant subdomains (Kitchen, in press). In 
a similar fashion, we used a series of deletions to identify chromatin opening domains in 
the CT (Fig. 4).  Beginning from the C-terminus, we found chromatin opening activity 
between residues 635-736, with partially active regions between 635-657, 658-678, and 
679-736.  With an N-terminal deletion series, we found opening activity between 575-
657 and 675-703, with the second region containing partially active regions, 675-702 and 
703-721. Deletion of 676-721 and 703-721 from the CT reduced array opening and 
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confirmed the activities of these domains.  Although results from the N- and C-terminal 
deletions generally agreed, there were some differences. In the C-terminal deletions, 
residues 575-634 had no activity by themselves, while removing 575-634 from the N-
terminal end reduced opening activity of the CT. Similarly, removing amino acids 635-
678 from the C-terminal side substantially reduced opening, whereas the N-terminal 
deletion of 629-674 had little effect or somewhat increased opening activity.  When 
measured in isolation, however, the opening activity of 629-678 was about one third of 
the full CT.  In addition, the high level of opening by 575-678 compared to the reduced 
activity of 629-678 indicated that residues 575-628 have some opening activity. Although 
these results indicated that 575-721 accounted for all of the opening activity, the limits of 
the full opening domain may be somewhat smaller, as deleting 606-721 from the full CT 
eliminated its opening activity.  Taken together, these results suggested that the CT 
region contains at least two opening domains, one from 606-657 and another from 675-
721, and that each region is composed of at least two partially redundant subdomains. 
CTCF’s AT-hook alters the structure of the lac operator array. 
After quantifying their opening activity, we assessed the morphology of arrays 
targeted by each of the CT region deletions.  We found that all fusions containing 
residues 657-678 induced structures with contiguous morphologies that were similar to 
ones opened by the full CT region (Fig. 5B-F and data not shown). However, any active 
CT deletion that lacked those residues produced structures with dispersed foci connected 
by fibrils that resembled those formed by the NT fusion (Fig. 5I-L). In addition to the 
contiguity it imparted, we observed that any fusion containing 657-678 also produced 
HSRs with intense DAPI staining, which equaled or exceeded the enhanced staining that 
is normally associated with the condensed HSR (compare Fig. 5B-F to A, G).  Re-
examining arrays opened by full length CTCF revealed similar DAPI-bright structures, 
whereas NT- and VP16-bound arrays showed no DAPI signal above the general nuclear 
staining (Fig. 5B, H and data not shown).  Similarly enhanced signal was also seen with 
ethidium bromide-stained arrays (data not shown), indicating that DAPI‟s preference for 
AT-rich sequences was not necessary for its increased binding.  
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AT-hooks are short motifs that bind AT-rich DNA sequences and are found in 
many chromatin-associated proteins. Aravind and Landsman identified an AT-hook in 
CTCF that is located within the 657-678 domain, and we asked if this motif is required 
for the contiguous morphology or the enhanced DAPI staining of CT-bound arrays 
(Aravind and Landsman, 1998).  Indeed, expression of LacR-CT with a mutated AT-
hook produced opened arrays with dispersed foci that generally lacked the contiguous 
structures induced by the wild type CT (Fig. 4I).  Moreover, arrays opened by the mutant 
LacR-CT were no longer DAPI-rich. In the context of LacR-[629-678], mutation of the 
AT-hook also reduced the small degree of array opening produced by this subdomain 
(Fig. 4L) and targeting the AT-hook alone to the array is not sufficient to drive 
decondensation (data not shown). However, the changes in array morphology that require 
the AT-hook indicate that this motif can alter the HSR‟s large-scale chromatin structure. 
Differential recruitment of transcriptional cofactors and induction of histone 
modifications by CTCF’s array opening domains 
At first, the morphological differences between NT- and CT-opened arrays 
suggested that each region uses distinct chromatin opening mechanisms. Much of that 
distinction, however, was lost upon mutation of the AT-hook in the CT. To address this 
issue further, we determined which factors each domain recruits to the HSR and which 
histone modifications are altered by their binding.  Before assessing each domain 
separately, we first established the utility of the assay by determining CTCF‟s 
recruitment of Chd8, cohesin (Smc1, Smc3, Rad21), nucleophosmin, Sumo-1, and Sumo-
3, which are factors known to be associated with CTCF (MacPherson et al., 2009; 
Parelho et al., 2008; Stedman et al., 2008; Wendt et al., 2008; Yusufzai and Felsenfeld, 
2004).  A03 cells were transfected with the LacR-CTCF expression plasmids, 
immunostained for each factor, and randomly chosen cells were scored for co-
localization of the factors with array-bound CTCF.  A factor was considered positive for 
co-localization if more than 30% of scored arrays showed staining coincident with the 
array that was higher than its general nuclear staining.  These experiments showed that 
LacR-CTCF consistently recruited all seven of these factors to the HSR (Fig. 6A-F and 
data not shown).  In all cases, the degree of cofactor recruitment by LacR-CTCF was 
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much higher than LacR, which was considered to be baseline (Table 1). We also found 
that NCoR, PCNA, RB, fibrillarin, and Brca1 did not co-localize with LacR-CTCF, 
which showed that it does not recruit indiscriminately (Fig. 6G, Table 1, and data not 
shown).  Thus, recruitment to the HSR appears to accurately reflect proteins previously 
shown to interact with endogenous CTCF.  
We then determined CTCF‟s recruitment of additional transcriptional cofactors 
and its induction of histone modifications.  Staining for the chromatin remodeling 
proteins, Brahma (Brm) and Mi-2, showed that CTCF efficiently recruited both factors to 
more than 70% of arrays.  We also stained for three HATs, CBP/p300, GCN5, andTip60, 
and found moderate recruitment (38%-61%) for each.  Correspondingly, 46% and 63% of 
CTCF-targeted arrays showed histone H4 and H3 hyperacetylation. We also assessed 
transcription at the array by staining for bulk Pol II and trimethylated H3K36 (Eissenberg 
and Shilatifard, 2006).  Their recruitment (16% Pol II and 30% H3K39me3) was negative 
by our strict criteria, but more than 2-fold above the LacR control.  
After establishing the assay with full length CTCF, we then determined which 
factors were recruited to the HSR by the NT and CT fusions (Table 1).  Staining for 
cohesin subunits showed recruitment by the NT fusion only.  Sumo-1 and -3 were highly 
recruited by both, which is consistent with known sumoylation sites (MacPherson et al., 
2009).  Brm was recruited by both regions, although the NT was more efficient than the 
CT (100% vs 65%).  Conversely, Chd8 localized to 90% of CT-targeted arrays compared 
to only 15% for NT arrays. Of the three HATs, all of them showed substantial 
recruitment by NT, but CT levels were at or below the LacR control. Consistent with the 
HAT recruitment, 60% of NT-targeted HSRs had a high level of H4 hyperacetylation, 
whereas CT- and LacR-targeted HSRs showed similarly low levels of histone 
hyperacetylation. For Pol II and trimethylated H3K36, more than 70% of NT arrays 
stained positively for both, compared to only 5% of CT arrays (Table 1). We also 
determined recruitment by the LacR-ZF fusion, and in all cases, the degree of 
immunostaining associated with the HSR was similar to the LacR control (data not 
shown). After finding that the CT recruited Brm, Mi-2, and Chd8, we then used 
immunostaining to examine their recruitment by its two separate opening domains (Fig. 7 
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and Table1).  Arrays targeted by LacR-[675-721] arrays showed strong recruitment of 
Brm and Mi-2, but not Chd8.  Conversely, LacR-[629-678] recruited Chd8, but not Brm 
or Mi-2.  The LacR-[675-721]‟s stronger recruitment of Mi-2 than the full CT could 
reflect its somewhat higher expression levels or the absence of an inhibitory domain. The 
overlapping but distinct cofactor recruitment by the N- and the C-terminal regions of 
CTCF suggests that they share some but not all aspects of their array unfolding pathways. 
CTCF’s transactivation domain recruits cohesin and transcriptional cofactors 
In Chapter 2, we found that the NTAD is necessary and sufficient for HSR 
decondensation and induction of H4 hyperacetylation (Kitchen and Schoenherr, 
submitted).  As it is responsible for the NT‟s opening activity, we immunostained 
NTAD-targeted HSRs and found that it recruited the same transcriptional cofactors as the 
full NT region and induced the same histone modifications (Fig. 8 and Table 1).  Most 
notably, the NTAD also recruited the same cohesin subunits as the full NT (Fig. 8G, H).  
Specifically, over 80% of NTAD arrays showed clear enrichments of the cohesion 
subunits Smc1, Smc3 and Rad21 (Table 1). We also found cohesin recruitment by three 
partially active subdomains of the NTAD (data not shown).  On the other hand, fusions of 
the amino acids flanking the NTAD, LacR-[1-43] and LacR–[183-270], did not alter the 
HSR and showed no cohesin staining (data not shown).  These results indicate that a 
transcriptional activation domain can localize cohesin to a transgene array and that the 
known poly (ADP)-ribosylation domain, [183-270], does not recruit cohesin. 
CTCF’s array altering activities are sensitive to ATP-depletion, but show 
differential sensitivity to a HAT inhibitor  
The patterns of cofactor recruitment by the array opening domains within the NT 
and CT suggested that each domain has common and unique aspects to their array 
unfolding pathways.  For example, each domain recruited the ATPase subunits of 
chromatin remodeling complexes, which suggested that array decondensation is likely to 
be an ATP-dependent process. Similarly, histone acetylation is often associated with 
open chromatin, and the presence of HATs at only NT-targeted arrays suggested that 
histone acetylation could contribute to its decondensation activity. To address these 
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possibilities, we first examined whether depleting cellular ATP by treatment with azide 
and 5-deoxyglucose could suppress array decondensation by the NTAD and two C-
terminal opening domains.  To prevent array opening before ATP depletion, A03 cells 
expressing LacR fusions to the NTAD, 629-678, or 675-721 were cultured in the 
presence of IPTG, which inhibits the LacR domain from binding to and opening the 
array. For cells expressing the NTAD and 675-721 fusions, we washed out the IPTG 36 
hrs after transfection, added media containing sodium azide and 5-deoxyglucose, fixed 
the cells after 2 hrs, and quantified the size of the arrays. For cells expressing LacR-[629-
678], azide and 5-deoxyglucose were not added until 8 hrs after IPTG removal, as this 
fusion requires 6-8 hrs before beginning decondensation.  Measuring the array areas 
showed that ATP depletion completely blocked any increase in size for all three fusions 
(Fig. 9A).  By comparison, arrays in parallel control cultures increased from 40% to 
100% in size during the 2 hr induction. 
To address the role of histone acetylation, we examined array decondensation by 
the NT and CT in the presence of anacardic acid, an inhibitor of HATs.  Anacardic acid 
inhibits a broad range of HATs, including p300/CBP, PCAF and Tip60 
(Balasubramanyam et al., 2003; Sun et al., 2006), and therefore is more likely to 
influence opening by NT than CT.  Cells expressing LacR-NT or -CT were cultured with 
IPTG which was washed out at 36 hrs after transfection, and replaced with media 
containing 50μM anacardic acid or 0.1% DMSO.  Cells were fixed after 12 hr of growth, 
and their array areas were quantified as before.  Compared to DMSO-treated control 
cells, treatment with anacardic acid reduced the mean area of NT-targeted HSR‟s by 
about 40% (Fig. 9B). Similar inhibition was seen with CTCF.  By contrast, the drug 
inhibited CT-induced opening of the HSR by only 10%, which was not statistically 
significant. Although all of the opening domains were inhibited by ATP depletion, 
anacardic acid‟s differential effect on HSR decondensation by the NT and CT supports 
the possibility that they have distinct aspects to their array decondensation pathways.  
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DISCUSSION  
CTCF is considered a chromatin architecture protein due to its association with 
long-range chromosomal interactions, open chromatin and positioned nucleosomes 
(Phillips and Corces, 2009; Wallace and Felsenfeld, 2007). However, how CTCF directs 
changes in chromatin and which domains it uses to perform these functions remain 
largely unknown.  Consistent with its association with open chromatin, we showed that 
CTCF is sufficient to recruit common transcriptional cofactors and to initiate 
decondensation of the condensed chromatin of a lac operator array. In addition, we 
identified and characterized three different domains that mediate CTCF‟s array opening 
activity. Each domain appears to use a distinct, but potentially overlapping, complement 
of proteins to modify chromatin structure. We also showed for the first time that an AT-
hook motif alters the large-scale structure of a transgene array. Finally, we found that 
CTCF‟s activation domain is sufficient to recruit the cohesin complex to the array. Given 
the importance of cohesin and CTCF for preventing enhancers from activating 
transcription of Igf2, this result provides the first evidence suggesting that an activation 
domain participates in enhancer blocking activity. 
The utility of transgene arrays 
We chose to use the lac operator array in A03 cells to address if and how CTCF 
alters chromatin, as the large array allows direct visualization of changes in chromatin 
structure and does not require ongoing transcription for decondensation to occur 
(Robinett et al., 1996; Tsukamoto et al., 2000).  Much like promoter fusion plasmids 
serve as reporters for transcriptional domains, this array can be used to uncover 
chromatin opening or altering activity that would have been missed by relying solely on 
transcription-based assays. For example, the CT region demonstrated almost no 
transcriptional activity using transfected reporters (Kitchen, submitted), but it has 
substantial array opening activity.  In addition to assessing decondensation per se, we and 
others have shown that the opened HSR can adopt distinct morphologies that could 
reflect recruitment of different proteins to the array (Nye et al., 2002; Stenoien et al., 
2001). Although the morphologies themselves might not be directly relevant to 
endogenous chromatin structure, the different activities of multiple transcriptional 
54 
 
cofactors almost certainly produced the unique HSR structures. Thus, array morphology 
serves as another assay for chromatin modifying activities that might not be detected by 
methods such as nuclease sensitivity mapping or 3C.  
Due to their visibility in the light microscope, large transgene arrays also allow 
direct detection of co-localization between endogenous proteins and DBD fusions using 
immunostaining.  Thus, transgene arrays provide a simple in vivo method for determining 
potential cofactor recruitment by transcriptional proteins and serve as a complement to in 
vitro interaction experiments. In support of this idea, cofactors previously shown to 
interact with GR, ER, VP16, and Brca1 were recruited to different transgene arrays by 
the appropriate DBD fusions (McNally et al., 2000; Memedula and Belmont, 2003; 
Stenoien et al., 2001; Ye et al., 2001).  However, it is important to note that recruitment 
to the array does not demonstrate direct protein-protein interactions. Instead, many 
proteins are likely to be recruited indirectly, as part of multisubunit complexes or after a 
cascade of events.  In addition, concentrated binding of fusion molecules to the tandem 
lac operators could lead to artificial recruitment of some factors. Thus, the recruited 
proteins that we have identified should be considered as likely candidates for CTCF 
cofactors. Moreover, given the diverse transcriptional roles ascribed to CTCF, it is also 
unlikely that all of the proteins found at the array will be recruited to all endogenous 
sites.  For example, using genome-wide localization data for CTCF and p300, we found 
that many sites overlap, but many more do not (data not shown).  From this and our array 
results, we argue that endogenous CTCF is not sufficient for strong p300 recruitment, but 
it contributes to the p300 localization at some sites.  The same argument would apply to 
the other recruited co-factors we identified. 
CTCF induces array decondensation and recruits transcriptional cofactors 
Although substantial evidence has linked CTCF to open chromatin, direct 
evidence for its chromatin opening activity is lacking.  Moreover, its chromatin 
modifying domains and potential cofactors are largely unknown.  We targeted CTCF to 
the array in A03 cells to address how it modifies chromatin and found that it was 
sufficient to induce substantial decondensation of the array.  We then showed that this 
activity resides within its NT and CT regions and that both regions had similar levels of 
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opening activity that were equally sensitive to ATP depletion.  However, we noted clear 
differences in the morphology of arrays opened by the NT and CT, which suggested that 
each region employed different chromatin modifying proteins.  Consistent with this idea, 
we found that each region recruited a distinct but overlapping set of transcriptional 
cofactors and induced different histone modifications.  More direct evidence for their use 
of distinct decondensation factors was provided by anacardic acid‟s specific inhibition of 
the NT‟s array opening activity, but not the CT‟s. While it is likely that anacardic acid‟s 
ability to inhibit a wide range of HATs prevented array opening by the NT, we cannot be 
certain, as the drug also inhibits prostaglandin synthase, lipoxygenase, and protein 
modification by SUMO (Fukuda et al., 2009; Grazzini et al., 1991).  However, our main 
conclusion that the NT and CT use distinct array decondensation pathways is not altered 
by anacardic acid‟s broad range of targets. 
Previously, we found that the transcriptional activation domain (NTAD) within 
the N-terminal region of CTCF exhibited chromatin opening activity resembling that of 
acidic activators (Kitchen, submitted).  In this report, we extended those results and found 
that CTCF, the full NT, and the NTAD recruited the same transcriptional cofactors as 
acidic activators such as VP16 (Memedula and Belmont, 2003).  Consistent with 
decondensation and increased histone hyperacetylation of the array, the NT recruited 
Brm, Mi-2 and several HATs (p300, Gcn5, and Tip60). This is the first demonstration 
that CTCF is sufficient to recruit specific components of multiple HAT and chromatin 
remodeling complexes to a transgene array. While recruitment of these coactivators could 
be array-specific, the NT also activates transcription in transient reporter assays (Kitchen, 
submitted) and in vitro (Vostrov et al., 2002). Moreover, the recruitment of remodeling 
complexes and HATs is consistent with the open chromatin and increased H3 and H4 
acetylation associated with some endogenous CTCF sites (Han et al., 2008; Splinter et 
al., 2006; Verona et al., 2008). Thus, we speculate that the NT region of CTCF is 
sufficient for or contributes to the recruitment of the same cofactors at these CTCF sites.  
Unlike its NT and CT regions, CTCF‟s zinc finger DNA binding domain never 
opened the array and did not recruit any of the factors we tested, including Chd8.  The 
absence of Chd8 was surprising, as the zinc finger domain was shown to interact with the 
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BRK domain of Chd8 in yeast two-hybrid experiments (Ishihara et al., 2006).  Moreover, 
CTCF‟s zinc fingers did not recruit the corepressor mSin3A (data not shown), which 
contrasts with GST pull-down results suggesting a direct protein interaction (Lutz et al., 
2000b).  The reasons for these conflicting results are unclear, but it is possible that our 
fusion did not fold properly or that our antibody staining was blocked or not sufficiently 
sensitive.  On the other hand, yeast two-hybrid and pull-down experiments also suffer 
from false positives, and it is possible that the reported direct interactions do not occur in 
vivo. Although further work will be required to clarify these discrepancies, our results 
suggest that CTCF‟s zinc finger domain does not recruit substantial chromatin altering 
activity. 
The CT‟s effects on the HSR shared both similarities and differences with the NT 
and other transcriptional activation domains.  The CT efficiently opened the HSR and 
recruited chromatin remodeling factors, such as Brm, Chd8 and Mi-2.  Although Chd8 
was found to interact with CTCF‟s zinc fingers, interactions with the CT were not 
excluded, and Chd8‟s recruitment by the CT is consistent with the loss of Igf2 imprinting 
associated with Chd8 knockdown (Ishihara et al., 2006).  In contrast to the activation 
domains, the CT did not recruit HATs or Pol II and induced almost no detectable H3 or 
H4 hyperacetylation. The absence of high levels of acetylation is consistent with the 
minimal effect that anacardic acid had on CT‟s opening activity and also suggests that H3 
and H4 hyperacetylation is not necessary for chromatin decondensation.  However, most 
CT-targeted arrays are positive for acetylated lysine16 of histone H4, which is associated 
with open chromatin (data not shown) (Shogren-Knaak et al., 2006).  The CT also did not 
recruit Pol II, which indicates that simply decondensing the large-scale structure of the 
array is not sufficient to induce transcription. It is also consistent with our work showing 
that the CT is almost transcriptionally neutral in transient transfection assays and with 
reports of repression by the CT (Kitchen, in press) (Lutz et al., 2000b).  Taken together, 
these results suggest that the CT has evolved to efficiently decondense chromatin without 
a concomitant activation of transcription.  However, the CT‟s inability to recruit Pol II 
conflicts with direct interactions detected in vitro between the CT and Pol II‟s largest 
subunit (Chernukhin et al., 2007).  Further work will be required to determine the source 
of these discrepancies.  
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CTCF has a functional AT-hook 
The CT region opened the array into structures that were distinct from any 
produced by the many different ADs targeted to the HSR.  Initially, we assumed that the 
unique structure of CT-opened arrays was due to their distinct complement of chromatin 
modifying proteins.  However, our deletion analysis uncovered two domains in the CT 
that produced arrays with dispersed foci similar to NT arrays. The change in array 
structure was coincident with deleting or mutating the CT‟s putative AT-hook, which is 
located between the two CT opening domains. The importance of the AT-hook for the 
cohesive morphology is the first example of this motif altering the large scale structure of 
a transgene array, and we speculate that it serves to tether disparate portions of the array 
together.  
The possibility that CTCF‟s AT-hook serves as a tether in the array system 
suggests that it may be doing the same at endogenous binding sites.  AT-hooks are 6-11 
amino acid motifs with a Gly-Arg-Pro core surrounded by basic residues that bind 
preferentially to AT-rich DNA sequences. The motif is often present in proteins 
associated with chromatin architecture, such as HMG family proteins, remodeling 
factors, and heterochromatin proteins (Aravind and Landsman, 1998). Although AT-
hooks are generally thought to mediate local chromatin interactions, there is evidence that 
the motif can tether separate regions of chromatin together.  For example, a small AT-
hook containing region is required for the MENT protein to induce large scale chromatin 
condensation in vivo and to mediate connections between separate polynucleosomal 
arrays in vitro (Springhetti et al., 2003).  Similarly, the Epstein-Barr protein EBNA-1 
tethers viral episomes to sister chromatids via its two AT-hooks (Sears et al., 2004). 
Based on this evidence and results from 3C experiments suggesting that CTCF tethers 
distant regulatory units together, we speculate that its AT-hook could provide some of 
that tethering activity. In this regard, we note that two Drosophila insulator proteins, 
dCTCF and Mod(mdg4), also have putative AT-hooks. Finally, CTCF has been found in 
the nuclear matrix fraction, and the AT-hook could associate with the AT-rich sequences 
commonly found there (Yusufzai and Felsenfeld, 2004). 
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In addition to its effects on the large-scale structure of arrays, CTCF‟s AT-hook 
also increased their staining with DAPI and other DNA dyes. At this point, we cannot 
distinguish whether the increased staining is due to a greater local concentration of DNA 
or better dye accessibility.   If the motif has tethering activity, then it could increase DNA 
concentration by holding portions of the array close to each other or to other regions of 
the genome. Alternatively, the AT-hook increased the array opening activity of the 629-
678 subdomain, which suggests that it can contribute to chromatin decondensation. Other 
AT-hook proteins have been shown to decondense chromatin by displacing histone H1 
(Catez et al., 2004), which could increase dye accessibility.  Whatever the mechanism, 
we have shown that the AT-hook functionally interacts with the array‟s chromatin, and 
we speculate that this also occurs at native CTCF sites. 
CTCF’s transcriptional activation domain recruits cohesin  
Several groups have shown a significant genome-wide colocalization of CTCF 
and cohesin sites (Parelho et al., 2008; Stedman et al., 2008; Wendt et al., 2008).  
Consistent with that association, we found that CTCF‟s transcriptional activation domain, 
the NTAD, efficiently recruits cohesin subunits to the transgene array.  These results 
suggest that the colocalization of CTCF and cohesin at endogenous genes requires the 
NTAD.  At this point, we do not know whether the NTAD recruits (or sequesters) 
cohesin by direct protein interaction or indirectly through auxiliary factors.  CTCF 
copurifies with the cohesin subunit Scc3, which suggests that sequestering may involve a 
direct interaction between the two proteins (Rubio et al., 2008).  Alternatively, the RSC 
chromatin remodeling complex is required for proper loading of cohesin in yeast, and 
CTCF could sequester cohesin via its recruitment of remodeling complexes (Huang et al., 
2004).  However, CTCF‟s CT region also decondenses chromatin and recruits 
remodeling complexes but does not recruit cohesin, which shows that the presence of 
remodeling complexes or altering the array‟s chromatin structure is not sufficient for 
cohesin accumulation. We speculate that the higher levels of histone hyperacetylation or 
ongoing transcription specific to the NT-targeted arrays influence cohesin recruitment. 
This idea is consistent with cohesin‟s accumulation at active genes in Drosophila 
(Misulovin et al., 2008).  
59 
 
At the imprinted Igf2/H19 locus, CTCF blocks enhancers from activating 
maternal Igf2 and mediates long range interactions.  Recently, knockdown of cohesin 
subunits was shown to disrupt these interactions and enhancer blocking activity at 
Igf2/H19 (Nativio et al., 2009). If CTCF‟s NTAD recruits cohesin at this locus, then 
these results suggest that a transcriptional activation domain participates in enhancer 
blocking and long range interactions. The use of activation domains in long range 
interactions is consistent with looping models for enhancer activity or the coalescing of 
regulatory sequences at polymerase factories.  However, there is an inherent 
contradiction in the participation of an activation domain in enhancer blocking.  To 
resolve this apparent conflict, we propose a four part model: 1) The NTAD is required 
because activation domains can recruit or sequester cohesin. 2) The NTAD‟s weak 
activation at a distance makes it essentially transcriptional neutral in this context 
(Kitchen, submitted).  3) While required for enhancer blocking, cohesin does not directly 
suppress enhancers. 4) Different regions of CTCF are directly involved in suppressing 
enhancer activity. 
CTCF and chromatin architecture 
In addition to blocking enhancers, insulators proteins are generally thought to 
have barrier activity, the ability to maintain a region of open chromatin by preventing the 
spread of heterochromatin (Tsukamoto et al., 2000). For CTCF, the nature and extent of 
its barrier activity remains unclear. For example, CTCF has not demonstrated the ability 
to consistently maintain transgene expression, which was the original defining assay for 
insulators (Hark et al., 2000; Recillas-Targa et al., 2002). However, there is substantial 
correlative data linking CTCF binding to open chromatin domains at endogenous loci 
(Bulger et al., 2003; Fu et al., 2008) and at transition points between regions enriched in 
repressive and active histone marks (Cuddapah et al., 2009).  Taken with its array 
opening activity, these results suggest that CTCF actively opposes heterochromatin via 
the ability of the NT and CT to open chromatin. As for why CTCF does not insulate 
transgenes, we speculate that chromosomal context regulates CTCF‟s chromatin opening 
activity.  In this regard, its modification by SUMO may play a role, as translational fusion 
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of Sumo-3 to the NT and CT largely suppressed its array opening activity (Kitchen, 
submitted and unpublished).  
Beyond insulation, CTCF also may be an important determinant of genomic 
architecture, as suggested by evidence that it forms chromatin loops via interactions with 
nuclear substructures or with itself, promoters and enhancers (Phillips and Corces, 2009; 
Wallace and Felsenfeld, 2007).  Our results suggest that CTCF‟s ability to recruit 
common transcriptional cofactors could contribute to its interactions with promoters and 
enhancers detected using 3C (Kurukuti et al., 2006; Murrell et al., 2004; Yoon et al., 
2007). We also speculate that CTCF uses its chromatin opening domains to aid chromatin 
loop formation.  By recruiting factors that decondense chromatin, CTCF makes itself 
more accessible, thereby promoting interactions with nuclear substructures and regulatory 
regions. Decondensed chromatin also is more flexible than condensed, which would 
facilitate active or passive movement of DNA-bound CTCF into different parts of the 
nucleus (Chuang et al., 2006; Nunez et al., 2008).  The apparent loss of enhancer 
blocking of Igf2 that follows the knockdown of Chd8 is consistent with these ideas 
(Ishihara and Sasaki, 2002). In summary, we have identified candidate chromatin opening 
and tethering domains in CTCF that could be used to establish and maintain 
chromosomal architecture.  
 
METHODS  
Plasmid constructs 
GFP- tagged LacR (pLacR) fusions to full length CTCF and its domains were 
made as described in the previous chapter.  Portions of the CT region were PCR 
amplified using primers with XbaI overhangs and ligated into pGFP-LacR.  PCR-based 
fusion constructs were sequenced to ensure fidelity, and correct protein expression was 
confirmed through Western-blot analysis.  
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Tissue culture, transient transfections, immunocytochemistry 
A03 cells were cultured and transfected as previously described, and coverslips 
were prepared for immunocytochemistry.  Coverslips were blocked at 4ºC in 5% normal 
goat serum for 30 min or 10% normal donkey serum for 1h (Sigma), and then washed 
three times for 5 min in PBST and incubated at 4°C for 24 h with a primary antibody 
diluted in PBST as follows:  1:200 dilutions of Santa Cruz rabbit anti-CBP/p300 (sc-
1211), anti-Gcn5 (sc-20698), anti-Tip60 (sc-25378), anti-Brahma (sc-28710), anti-Brg1 
(sc-10768), and anti-Pol II (Polr2a, N-20, sc-899); 1:500 of Serotec rabbit anti-acetylated 
histone H3 (AHP412) and H4 (AHP418); 1:500 of Upstate rabbit anti-trimethyl-Histone 
H3 Lys9 (07-442), H3 Lys27 (07-449), and H3 Lys36 (07-549).  Rabbit anti-Mi2 was a 
gift from Dr. Peter Jones and used at a 1:500 dilution (60).  Antibody specificity was 
confirmed via Western blot analysis of CHO-K1 nuclear cell lysate. After primary 
antibody incubation, coverslips were washed three times for 5 min in PBST and then 
incubated at 4°C for 12 h with secondary antibody:  1:1000 dilution of Texas Red goat 
anti-rabbit or goat anti-mouse IgGs (Jackson ImmunoResearch) or 1:3000 dilution of 
Alexa 594 donkey anti-goat IgG (Invitrogen).  Coverslips were then washed three times 
for 5 min, stained with DAPI, and mounted onto slides as described.  
To assess co-localization at the HSR, coverslips from three separate transfections 
of A03 cells were stained with each antibody. Approximately 30 nuclei from randomly 
chosen fields were observed per coverslip for imaging.  In each case, 60-100 raw images 
of antibody staining were scored for each of the GFP-LacR fusions.  Co-labeling of the 
HSR was scored as negative if there was an absence of staining at the HSR and positive if 
the staining was both clearly associated with the HSR and similar to or greater than the 
general nuclear staining.  
Imaging and image analysis 
Raw images were saved as individual files and deconvolved as described 
previously.  Selected images were processed and analyzed using the ImageJ software 
program.  The automated microscopy system described previously was used with the 
same criteria for excluding untransfected and low expressing cells and manually omitted 
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over-expressed GFP fusion expressing cells. Each fusion was assessed in triplicate with 
at least 50 cells measured in each replicate.  For each data set, the HSR areas were 
depicted using box plots with end lines showing the 10th and 90th percentiles, box ends 
showing the 25th and 75th percentiles, and the center line indicating the 50th percentile. 
The arrays were defined as “fully opened” when they exceed an area of 5.72 µm2 (495 
pixels), which is three standard deviations from the mean area of control GFP-LacR 
labeled HSRs (2.07 µm2 ±1.21 µm).  The p values were obtained using Microsoft Excel 
and are step-down Bonferroni adjusted t-tests assuming equal variance based on each of 
the three experiments producing one measurement. 
To measure the length of contiguous GFP signal, the threshold function in ImageJ 
was used to set each image such that only one pixel was saturated to normalize GFP 
intensity across the individual images. The longest fluorescent structure was identified, 
and a path was drawn that bisected the structure and connected the two most distant 
points. The program determined the length of the path, and this length was plotted against 
the total area of the HSR. A minimum of 40 HSRs targeted by GFP-LacR fused to VP16, 
CTCF, NT, or CT was deconvolved before measurements were taken. 
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FIGURES & TABLE 
 
 
Figure 3.1  The lac operator array and lac repressor fusion constructs.  (A) Illustration of A03 cells 
and the “homogenously staining region” (HSR), a condensed chromatin structure comprising co-amplified 
concatamers of a vector with 256 direct lac operator repeats and genomic DNA.  (B) Schematic of the GFP-
lac repressor fusion constructs. GFP, enhanced green fluorescent protein; LacR, lac repressor DNA binding 
domain; NLS, SV40 nuclear localization signal; NT, ZFs, and CT indicate the N-terminal region, the zinc 
finger DNA-binding domain, and the C-terminal region of CTCF.  The amino acid residues are indicated 
below each construct.   
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Figure 3.2  CTCF and its N- and C-terminal regions induce large-scale decondensation of the HSR.  
Plasmids expressing the indicated GFP-LacR fusions were transfected into A03 cells.  (A-F) Examples of 
highly decondensed HSRs induced by targeting GFP-LacR fused to VP16, CTCF, NT and CT.  The HSR 
remains condensed when targeted by the ZFs region.  Images are deconvolved optical sections of 
transfected nuclei with the left panel showing DAPI staining (blue) merged with GFP signal (green).  The 
right panel is an enlarged gray-scale image of the HSR with the manually determined area of GFP signal 
shown at the bottom.   Scale bars, 1 µm.  (G) Box plots of targeted HSR areas determined using an 
automated microscopy and image analysis system.  The table details the percent of “fully opened” arrays; 
the mean area of the HSRs (µm2); the p-values for t-tests of the mean areas compared to GFP-LacR alone; 
and the total number (n) of analyzed nuclei.    
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Figure 3.3  The HSR adopts morphologically distinct structures when opened by CTCF’s N- and 
C-terminal regions.  Plasmids expressing LacR fusions were transfected into A03 cells. (A-D) 
Examples of HSR decondensation induced by targeting GFP-LacR fused to the NT (A), CT (C), or 
full-length regions of CTCF (B, D).  The left most panels are projected z-stacks of the deconvolved 
series followed by five optical sections at 0.4 µm increments shown on the right.    Scale bars, 1 µm.  
(E)  The longest length of contiguous GFP signal was measured from deconvolved optical sections and 
plotted against its respective HSR area.  Linear regression trendlines are shown.                                                                                                                                     
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Figure 3.4  Mapping the array opening activities in CTCF’s CT region.  A03 cells were transfected 
with plasmids expressing LacR fused to segments of the CT.  Areas of targeted HSRs were determined 
using an automated microscopy system and image analysis system.  The first column shows the portions of 
the CT fused to LacR with the amino acid residues indicated below each construct.  The next columns 
report the percent of “fully opened” HSR arrays and the mean area of all measured arrays (µm2).  The box 
plots show the distribution of array areas. 
67 
 
                                                                                                                                            
Figure 3.5  CTCF’s AT-hook alters the structure of the HSR.  A03 cells were transfected with plasmids 
expressing LacR fused to the indicated segments of CTCF. (A-L) The images are deconvolved optical 
sections with the left panel showing DAPI staining (blue), the middle shows GFP signal (red), and the right 
merge the DAPI and GFP signals.  Light purple indicates overlay. The numbers indicate the residues of 
CTCF. (B-F) Increased DAPI staining of the HSR when targeted by domains containing CTCF‟s AT-hook.  
(H-L) The absence of increased DAPI staining of the HSR when targeted by domains lacking CTCF‟s AT-
hook. The NTAD are residues 44-150, and AThM refers to mutations in the AT-hook.  (A,G) The DAPI-
rich condensed HSRs targeted by LacR alone (A) or LacR-ZFs (G). Scale Bar, 1 µm. 
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Figure 3.6  Known CTCF interacting proteins recruited to the HSR by LacR-CTCF fusion.  A03 cells 
were transfected with plasmids expressing LacR-CTCF and assessed for co-factor recruitment by 
immunofluorescent staining.  The images are deconvolved optical sections of the HSR stained for: (A) 
Chromodomain 8, Chd8; (B) nucleophosmin; (C, D) Cohesin subunits, Smc1 and Smc3; (E, F) HA-tagged 
Sumo-1 and Sumo-3; (G) Nuclear receptor corepressor, NCoR.  The left panels show the fluorescent 
staining for each co-factor (red), the middle show GFP tagged LacR-CTCF (green), and the right show the 
merge. Yellow indicates overlay and recruitment to the HSR. 
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Figure 3.7 The CT opening domains recruit chromatin remodeling proteins to the HSR.  A03 cells 
were transfected with plasmids expressing LacR-CT, -[629-678], or -[675-721] and analyzed for co-factor 
recruitment by immunofluorescent staining.  (A-C, F-H) The images are deconvolved optical sections of 
CT-targeted-HSRs stained for: (A) Brahma, (B) Chd8, (C) Gcn5, (F) histone H4 hyperacetylation, (G) Pol 
IIn, (H) Smc1.  (D, I) Images of HSR staining when targeted by LacR-[629-678]. (D) Brahma  (I) Chd8.  
(E, J) Images of HSR staining when targeted by LacR-[675-721]. (E) Brahma  (J) Chd8.  Each panel shows 
the merged image of the GFP (green) and Texas Red (red) signals with yellow indicating recruitment to the 
HSR. 
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Figure 3.8  Cohesin and transcriptional co-factor recruitment by CTCF’s activation domain.  A03 
cells were transfected with plasmids expressing LacR-NTAD and analyzed for co-factor recruitment by 
immunofluorescent staining. The images are deconvolved optical sections of HSR staining for: (A) 
Brahma, (B) Chd8, (C) Mi-2, (D) Gcn5, (E) H4 hyperacetylation, (F) Pol IIn, (G) Smc1, and (H) Smc3.  
Each panel shows a merged image of GFP (green) and Texas Red (red) signals with yellow indicating 
recruitment to the HSR. 
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Figure 3.9  Sensitivity of CTCF’s chromatin opening domains to ATP depletion and HAT inhibition.  
A03 cells were transfected with plasmids expressing LacR fused to CTCF‟s array opening domains in the 
presence of IPTG.  The IPTG was removed 36 hrs after transfection, and drugs were added for ATP 
depletion (A) or HAT inhibition (B).  Bar graphs show the mean areas of arrays determined using an 
automated microscopy system.  (A) ATP depletion. After IPTG removal, the cells were then cultured for 
2hrs (LacR-NTAD and –[629-678] expressing cells) or 8 hrs (LacR-[675-721] expressing cells) to allow 
array opening to begin.  Control cultures for each construct were fixed at this time to determine the starting 
array size before drug addition (green bars).  To deplete cellular ATP, sodium azide and deoxyglucose were 
added to the medium and cells were incubated for an additional 2 hrs and then fixed (blue bars). Control 
cultures with only DMSO added were prepared in parallel (purple bars). (B) HAT inhibition. After IPTG 
removal, transfected cells were cultured for 12 hrs in the presence of anacardic acid or DMSO. The blue 
and red bars show arrays areas in the presence of DMSO and anacardic acid, respectively.  Error bars 
indicate standard deviation. 
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CHAPTER 4: THE C-TERMINAL REGION OF CTCF 
HAS ENHANCER BLOCKING ACTIVITY 
 
INTRODUCTION 
CTCF is an evolutionarily conserved zinc finger protein that has emerged as a 
unique transcription factor with multifunctional capabilities (Ohlsson et al., 2009; 
Ohlsson et al., 2001; Phillips and Corces, 2009).  Since its discovery, a growing number 
of target sites have linked CTCF-binding to local cellular responses, including gene 
repression (Awad et al., 1999; Burcin et al., 1997; Ohlsson et al., 2001; Renaud et al., 
2005); activation (Ohlsson et al.; Tam et al., 2003; Vostrov et al., 2002); imprinting 
(Fitzpatrick et al., 2007; Hark et al., 2000; Wylie et al., 2000); and insulation (Filippova, 
2008).  Using genome-wide ChIP, thousands of CTCF sites have been identified 
throughout the genome, which supports its proposed role as a “master weaver” of nuclear 
architecture and dynamics (Phillips and Corces, 2009).   
CTCF is perhaps most well-known for its role in insulator function.  It is the only 
vertebrate protein to contribute to the enhancer blocking (EB) activity of insulators 
(Wendt and Peters, 2009; Zlatanova and Caiafa, 2009).  CTCF has also been linked to the 
barrier function at some, but not all, insulators (Cuddapah et al., 2009).  By definition, an 
enhancer blocker has the ability to prevent enhancers from activating a promoter when 
placed directly between the two response elements (Felsenfeld et al., 2004).  This 
positional function separates an enhancer blocker from a repressor protein that can 
repress regardless of location.  Despite the interest in CTCF, the mechanism of its EB 
remains poorly understood. 
Recent investigations have associated CTCF‟s insulator function to protein 
partners such as the cohesion complex, CHD8, and nucleophosmin (Gause et al., 2008; 
Ishihara et al., 2006; Parelho et al., 2008; Rubio et al., 2008; Stedman et al., 2008; Wendt 
et al., 2008; Yusufzai et al., 2004).  The potential role of posttranslational modifications 
on CTCF‟s insulator function has also been an area of recent interest.  CTCF has been 
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shown to be post-translational modified by phosphorylation, poly (ADP) ribosylation 
(PARlation), and sumoylation.  CTCF phosphorylation has been shown to influence its 
repressive activity at the c-myc promoter, while PARlation  has been implicated in 
insulator activity (Delgado et al., 1999; Klenova et al., 2001; Yu et al., 2004).  
MacPherson et al. reported that CTCF can be modified by SUMO-1, -2, and -3 through 
sites in the N-and C-terminal regions and that sumoylation leads to repression activity at 
the c-Myc promoter (MacPherson et al., 2009).   
 SUMO (for small ubiquitin-like modifier) proteins are part of the ubiquitin-like 
family of peptides that are covalently attached to their protein targets.  There are three 
forms of the SUMO proteins; SUMO-1, -2, and -3, where SUMO-2 and -3 are virtually 
identical (97% sequence identity) and SUMO-1 has 50 % homology to the other two.  
The SUMO proteins are roughly 100 amino acids in length and their structure is similar 
to ubiquitin, although they share only about 18% sequence identity.  Nevertheless, 
protein modification by SUMO proceed via a similar pathway to ubiquitin, involving a 
specific E1 and E2 (Muller et al., 2004). Unlike ubiquitin, however, the modification of a 
protein by SUMO is a single conjugated peptide, rather than a poly-linked peptide chain.  
Furthermore, the SUMO E2 protein, Ubc9, recognizes the ψKKE motif and does not 
require an E3 for this interaction.  The known SUMO-specific E3s, therefore, enhance 
sumoylation (Chinnadurai, 2007; Wotton and Merrill, 2007).  Likewise, the sumoylation 
of a protein generally does not lead to degradation of the protein; rather this modification 
often alters the functional activity of its target protein.  
 A growing list of proteins have been identified with a SUMO modification, 
including proteins involved in DNA repair (Ouyang et al., 2009c), chromatin structure 
(Ouyang and Gill, 2009), and transcriptional regulation (Hofmann et al., 2005; Muller et 
al., 2004).  Generally, sumoylation has been associated with transcriptional repression 
(Ouyang et al., 2009b).  A key player in the repressive activity of SUMO-modified 
transcription factors is the corepressor CoREST1, which forms a complex with LSD1 and 
HDACs.  CoREST1 binds directly to SUMO 2, but not SUMO 1.  Disruption of the 
CoREST1/SUMO 2 interaction alleviates repression and alters the chromatin structure at 
several genes (Ouyang et al., 2009a).  Interestingly, in addition to repression, SUMO-
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modification has also been linked to the gypsy chromatin insulator in Drosophila, and the  
long-range interactions of insulator proteins can be disrupted by sumoylation (Capelson 
and Corces, 2006).  
Previous methods for assaying EB have been labor intensive and impractical for 
domain mapping studies (Bell and Felsenfeld, 1999).  Moreover, the use of endogenous 
loci requires the knockdown and replacement of endogenous CTCF.  Consequently, in 
this chapter, we developed some awesome reporter assays that could answer the EB 
riddle.  With these assays, we found that the C-terminal region of CTCF contains EB 
activity and full activity requires sumoylation.  Thus we have mapped a potential 
enhancer blocking domain and linked its activity to a specific post-translational 
modification.  Moreover, the EB activity does not appear to require the LSD1-CoREST1-
HDAC interaction with SUMO-2.  We propose that sumoylation of CTCF is a key factor 
that determines its functional role at a given locus and that the modification helps to drive 
the chromatin context for EB activity.  
 
RESULTS 
Direct-fusion assay  
In transient transfection assays, CTCF has been reported to both activate and 
repress transcription (Ohlsson et al., 2001).  Measuring EB activity, however, has 
generally been performed with integrated reporters, but this technique is cumbersome and 
often is masked by reporter silencing.  Thus, we sought transient transfection models that 
would detect the enhancer blocking activity of CTCF.  Based on work showing fusion to 
sumoylation domains to activator proteins suppress their activity (Ouyang et al., 2009b), 
we determined if translational fusions of CTCF domains to an activation domain could 
“block” its activity.  Specifically, we fused portions of CTCF to the C-terminus of the 
activation domain of RelA (p65) fused to the DNA binding domain (DBD) of a GFP-
tagged Lac repressor (LacR).  Initially, we examined CTCF domains from the NT region 
(1-270), including domain fusions to the NTAD and to NT-P (an NT domain with the 
PARlation site, 183-270), and also the CT region (575-736).  We then examined what 
affects the p65-CTCF domains would have on the reporter plasmid 8L-Luc, consisting of 
76 
 
eight sites for LacR upstream of a minimal TATA box driving a luciferase gene (Figure 
1A).    
We found that the p65-CT fusion showed striking affects as it reduced p65 
activation by over 150-fold.  The p65-NT and -NT-P fusions showed a more modest 6-7 
fold reduction, while p65-NTAD reduced p65 activation about 2-fold.  We also created a 
fusion where the CT domain was inserted N-terminal to p65 (CT-p65).  This fusion also 
reduced transactivation over 100-fold, suggesting that a carboxy-conjugation did not 
factor into the CT domain‟s repressive activity (Figure 1B).  Moreover, fusing the CT 
domain to the potent activation domain of VP16 showed over a 10-fold reduction in 
transactivation, whereas the NT domains fused to VP16 show no reduced activity (data 
not shown).  Western blot analysis showed similar expression levels for all of the fusions 
(data not shown).  Thus, direct fusion of the CT region can significantly reduce the 
activity of a potent activation domain, whereas the NT domains only showed a modest 
reduction in transactivation. 
      
Position-dependent assay 
The results of the “direct fusion” assay suggested that the CT region of CTCF 
might contain domain for EB activity.  To better distinguish between EB and repressor 
activity, we developed an assay to address the position dependence of EB.  We 
constructed a luciferase reporter with lac operators upstream of Gal4 UAS‟s, which are 
adjacent to the E1b-TATA promoter (p8L5G-Luc).  With this construct we could target 
both Gal4 and LacR fusions to the same promoter and, therefore, target domains in either 
a blocking position or a neutral position upstream of the interaction (Figure 2A).  From 
the upstream or “neutral” position, LacR-CTCF derivatives should have minimal 
blocking affects on p65 activation.  To target CTCF fusions to the “blocking” position 
(between p65 and the promoter), we reversed the DBDs and used LacR-p65 with Gal4-
CTCF derivatives.  These conditions allowed us to address if CTCF acts as an enhancer 
blocker or repressor protein.   
While the fold-reduction was not as striking as the direct fusions, we found that 
the CT domain reduced p65 transactivation about 5-fold when in the blocking position 
(Figure 2B).  Conversely, none of the NT domains showed any blocking activity.  In fact, 
both the NT region and NTAD enhanced the activation over 2-fold when located in the 
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blocking position.  This result was not surprising, however, since we had shown 
previously that the NT has moderate activation when directly upstream of a minimal 
promoter.  In addition, we found that all of the CTCF domains showed little or no effects 
on p65 activation when placed upstream in the neutral position (Figure 2B and data not 
shown).  This suggests that reduction in p65 activation by the CT region requires proper 
positioning between an enhancer and promoter, which distinguishes it from a repression 
domain.   
Mapping CTCF’s EB activity 
To map the potential CTCF EB domain, we performed a deletion analysis of the 
CT region.  Previously, we and others had characterized functional domains and 
modification sites within the CT region, including a AT-hook region, phosphorylation 
sites, sumoylation sites, and chromatin-opening domains (Klenova et al., 2001; 
MacPherson et al., 2009) (Kitchen, in press).  Based on this data, we tested three CT 
domains; 575-634, 629-678, 675-721, in the direct-fusion and position-dependent assays.  
We found that the AT-hook domain (629-678) showed little to no affect on p65 
transactivation in either assay.  The 575-634 and 675-721 domains, however, showed 
significant blocking activity in each assay.  In the direct-fusion assay, both 575-634 and 
675-721 reduced p65 activity by about 50-fold and in the position-dependant assay, the 
phosphorylation domain (575-634) inhibited activity 50%, while the sumoylation domain 
(675-721) reduced activation by almost 7-fold.  Thus, while both showed EB activity, the 
sumoylation domain was the more active. 
 
Assessing the effects of sumoylation on EB 
The presence of a known sumoylation site and the strong inhibitory activity of the 
675-721 domain suggested that the CT‟s EB required sumoylation.  In addition, there is a 
weak consensus site in 575-634, which could contribute to its activity.  Consequently, we 
mutated the two potential SUMO motif sites in the context of the full CT region (CTRR) 
and the smaller domains, 575-634R and 675-721R, where “R” indicates a lysine to 
arginine mutation.  The arginine mutation prevents sumoylation from occurring at the 
SUMO site, while maintaining a positively charged residue.     
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In the direct-fusion assay, mutations in both SUMO sites (CTRR) reduced 
blocking activity by 5-fold.  However, p65-CTRR still blocked p65 activation 30-fold in 
the direct-fusion assay (Figure 4A) and 50% in the position-dependent assay (Figure 4B).  
Most of the loss in blocking activity came from the site in 675-721, as mutants to just the 
first SUMO site, p65-CTRK and -575-634R, only reduced blocking 2-fold.  The most 
striking changes in blocking was seen with p65-675-721R, which reduced EB activity by 
nearly 20-fold.  Moreover, 675-721R did not block p65 activation in the position-
dependant assay (Figure 4B).   The reduction in blocking due to mutations in the SUMO 
motif sites suggested that sumoylation plays a key role in enhancer blocking.  We did 
note, however, that a significant EB-like activity still existed in both assays even with 
both SUMO sites mutated (CTRR) (Figure 4).   
In addition to conjugation sites we noticed acidic residues in the 675-721 domain 
that could form part of the recognition motif for the SUMO E2 conjugation protein, 
Ubc9.  We also speculated that the isoleucine residues in this region might act as a 
“SIM”, or SUMO-interacting motif (Hecker et al., 2006; Huggins et al., 1999; Perry et 
al., 2008).  SIM‟s have been found in transcription repressors like MCAF1 (Sekiyama et 
al., 2008).  Therefore, we mutated the putative Ubc9 motif and SIM by changing either 
the acidic residues or isoleucines to alanines.  As a direct-fusion, we found that the SIM 
mutant (p65-675-721I) did not affect enhancer blocking, whereas the 675-721U reduced 
blocking by 15-fold, suggesting these residues are important for Ubc9 binding and 
sumoylation (Figure 4).   
 
Assessing the effects on sumoylation on chromatin opening 
Repression by sumoylation has been shown to utilize the LSD1/ CoREST1/ 
HDAC2 complex through direct binding of SUMO-2/3 and CoREST1 (Ouyang et al., 
2009a).  Previously, we found that a direct fusion of SUMO-2 and -3 to the NTAD 
blocked its transactivation and prevented NTAD decondensation in our chromatin-
opening assay (Kitchen and Schoenherr, in press).  Moreover, we showed that mutating 
the CoREST1 binding site in SUMO-3 (S3-S) alleviated the transcriptional and opening 
suppression by the NTAD-S3 fusion (see Chapter 2 for details).  To examine the role of 
CoREST1 in our EB assays, we performed a COREST knockdown in CHO cells.  
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However, the CoREST knockdown did not affect EB‟s affects on transactivation in either 
assay (data not shown). 
While the 675-721 domain does not show transactivation, it does have strong 
chromatin opening activity similar to NTAD.  We wanted to examine how a direct fusion 
to SUM-3 would affect the opening activity of a transcriptional neutral, enhancer 
blocking domain.  In the chromatin opening assay, targeting the SUMo-3 fusions, 675-
721-S3 and CT-S3, to the transgene arrays did not induce significant opening (Figure 5 
and data not shown.)  Moreover, CoREST knockdowns did not affect the opening activity 
for CT-S3.  Conversely, NTAD-S3‟s transactivation and chromatin opening were both 
affected by the CoREST1 knockdown (Figure 5 and data not shown).  Thus, the 
CoREST1-SUMO machinery is likely specific to NTAD‟s repression, but is not 
necessary for CT‟s EB activity.     
 
DISCUSSION 
By designing two reporter-based enhancer blocking assays, we were able to 
demonstrate that the CT sumoylation domain, 675-721, has strong blocking activity in a 
position-dependent manner.  SUMO conjugation of 675-721, however, does not 
necessarily prevent 675-721 from a chromatin opening activity as recruitment of HA-
SUMO-3 to the transgene array by 675-721 did not alter its opening activity.  Moreover, 
while HA-SUMO-3 was not recruited to arrays with SUMO-conjugated mutants, 675-
721R did not induce significant changes in the opening activity.  However, SUMO-3 
translational fusions inhibited opening activity in all fusions tested, which suggests that 
forced sumoylation on all fusions impedes the chromatin decondensation pathway.  Or 
rather, a SUMO repression pathway overrides normal functionality.  Interestingly, the 
Ubc9 mutant 675-721U prevented opening of the transgene array, suggesting that the 
acidic residues are necessary for opening activity.  Future examination will be necessary 
to determine if the Ubc9 interaction directly influences this opening activity.  Overall, we 
suggest that the sumoylation complex influences CT enhancer blocking through a 
chromatin decondensation pathway. 
  We speculate that chromatin decondensation is another feature that distinguishes 
an enhancer blocker from a classical repressor.  With this in mind, SUMO‟s blocking 
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affects are independent of the CoREST repression complex.  On the other hand, 
sumoylation of the NTAD suppresses its transactivation and chromatin-opening in part 
through the CoREST1 complex.  Moreover, the SUMO-modified NTAD did not 
contribute to EB activity.  CoREST1 likely plays a role in the down-regulation of 
CTCF‟s activation domain.    Moreover, our data suggests that both the SUMO 
conjugation site and an Ubc9-binding motif are important to EB activity.  It will be 
interesting to examine if mutations in both the Ubc9 and SUMO conjugation sites remove 
all enhancer blocking.  In a CTCF context, the N-terminal and C-terminal SUMO sites 
are likely modified uniformly and act in concert at endogenous loci to inhibit activation 
and induce enhancer blocking (Figure 6).   
Previously, it was shown that sumoylation of CTCF influences repression at the c-
myc promoter (MacPherson et al., 2009).  We cannot entirely rule out that the CT region, 
including the sumoylation domain, are repressors.  Nevertheless, we showed earlier that 
the CT region does not harbor a strong repression domain, and in CHO cells, 
transfections with CT have a mild activation at proximal promoter sites (~2.6 fold) 
(Kitchen and Schoenherr, in press).  Moreover, the position-dependent assay is a clear 
indicator that the CT region acts as an enhancer blocker and not a repressor. 
While the modest reduction seen in the direct-fusion assay by each p65 fusion 
may be a result of intrinsic repressive activities, we believe that translational fusions to 
the C-terminal may partially cause this reduction.  A previously determined “neutral” 
domain of CTCF (amino acids 1-40) also reduced transcription over 3-fold in this assay 
(data not shown).  For this reason, we confirmed CT‟s blocking affect by reversing the 
fusion position (CT-p65) and showed similar blocking activity.  Preliminary work with a 
repressor protein in the neutral position of the position-dependent assay repressed p65 
activation where the LacR-CT derivatives did not (data not shown).  Although enhancer 
blocking sites at endogenous loci are typically not located proximal to the promoter, we 
feel these assays accurately implicate the CT sumoylation domain in enhancer blocking 
activity.    
In conclusion, the 675-721 domain has potent chromatin opening activity and 
recruits chromatin remodeling proteins like Brahma and Mi2 (Kitchen et. al., submitted).  
This domain also recruits SUMO proteins and harbors the enhancer blocking activity of 
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CTCF.  These functions are likely to be synergistic components to the enhancer blocking 
mechanism, and not opposing activities.  The population of endogenous CTCF-SUMO is 
less than 10%, but the small subset may be sufficient to induce the proper CTCF 
response.  For this reason, we believe that the chromatin-opening activity participates in 
EB activity and that sumoylation of CTCF establishes the opened chromatin at a given 
loci as “inactive.”  Thus, CTCF‟s multifunctional activities, like enhancer blocking, can 
be focused through post-translational sumoylation. 
 
METHODS 
 
Plasmid constructs 
pLacR-p65 was modified with a unique SpeI site at the C-terminus, and portions 
of CTCF were ligated in frame to the plasmid.  The pLacR and pGal4 fusions as 
described in Chapter 2 were also used in this study.  Fusion constructs were sequenced to 
ensure fidelity and protein expression was confirmed through Western-blot analysis (data 
not shown).  Point mutations were generated by overlapping PCR.  The p8L-Luc reporter 
was used for the direct fusion assay, while p8L5G-Luc was made by inserting the five 
Gal4s into the XhoI/SacI sites of p8L-Luc and used for the enhancer blocking assay.   
Tissue culture, transient transfections and luciferase assays 
CHO and A03 cells were used for this chapter as previously described. Transient 
transfections in the enhancer blocking assay consisted of 500 ng of p8L5G-Luc, 200 ng 
of the p65 fusion, 400 ng of the CTCF domain fusions, and 100 ng of β-gal with 4 µl of 
TransIT-LT1. All other transfections, luciferase assays, and image analysis were 
performed as described in previous chapters.       
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FIGURES 
 
 
 
Figure 4.1 Direct-fusion assay. (A) Schematic indicating the fusion constructs used with the DBD (LacR), 
the activation domain (p65), and the C-terminal fused modifying CTCF domain.  (B) Relative luciferase 
expression from CHO cells transfected with the p8L-Luc reporter and the p65-CTCF fusions; including the 
NT (1-270), the sumo site NT-S (44-150), the parp site NT-P (183-270), and the CT (575-736).  The CT-
p65 fusion was derived by cloning CT into the pGFP-LacR construct followed by a C-terminal insertion of 
the p65 activation domain.  
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Figure 4.2 Position-dependent assay. (A) Schematic indicating the fusion constructs used with the 8L5G-
Luc reporter plasmid in the Neutral position or the Blocking position.  (B) Relative luciferase expression 
from CHO cells transfected with the p8L5G-Luc reporter being activated by p65 with either LacR-CTCF 
derivatives (neutral) or Gal4-CTCF derivatives (BLOCK). 
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Figure 4.3 Mapping the CT enhancer blocking activity.  Domains of the CT regions were transiently 
transfected with a luciferase reporter as either direct fusions (A) or as Gal4 fusions (B) placed between the 
LacR-p65 fusion and the promoter.  Relative luciferase activity is shown.    
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Figure 4.4 Assessing the sumoylation effects on enhancer blocking.  Domains of the CT region 
containing point mutations (K to R) that prevent the SUMO conjugation were tested in the direct fusion 
assay (A) and the enhancer blocking assay (B).  Point mutations made to the Ubc9-binding motif (675-
721U) and to the putative SIM domain (675-721I) were assessed in the direct-fusion assay only.  
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Figure. 4.5 Sumoylation affects chromatin opening.  Mean area of HSR areas when targeted by NTAD 
or CT  and its translational fusions to Sumo 3.  The table below the box plots indicates the opening activity 
in the presence of control scramble or CoRest knockdown.   
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Figure 4.6 Model for CTCF insulator function.  (A) Barrier activity by CTCF likely requires the 
chromatin opening domains in the NT and CT regions, by recruiting chromatin remodeling and HAT 
complexes.  (B) Enhancer blocking activity by CTCF likely requires the posttranslational modification of 
SUMO. 
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CHAPTER 5: CONCLUSIONS 
At the onset of this work, CTCF was a protein of interest to those studying 
genomic imprinting and insulator function.  Virtually no significant structure or function 
studies of the protein had been published and its role in chromatin structure had yet to be 
discovered.  However, participation by CTCF in such diverse processes as transcriptional 
activation or repression, imprinting, and insulator function suggested that it has multiple 
functional domains that regulate transcription and modify chromatin structure.  Our initial 
goal was to identify the domain of CTCF involved in enhancer blocking activity.  Our 
first approaches to this goal were unsuccessful and we had to alter our direction.  
Consequently, we described in this manuscript the application of an array-based 
chromatin unfolding assay (Belmont et al., 1999) that provided evidence for the direct 
role that CTCF plays in chromatin structure.  Moreover, the array system allowed us to 
characterize several functional domains and to identify protein partners and post-
translational sumoylation as necessary for these functions.  We have significantly 
contributed to the functional mapping of this multifaceted transcription factor by 
characterizing activation, chromatin opening, and enhancer blocking domains in CTCF.  
A summary graphic of the domains that we have identified can be found in figure 1.    
In chapter 2, we used transient and integrated reporters to identify a 107 amino 
acid domain (NTAD) in CTCF‟s N-terminal region that is capable of transcriptional 
activation and chromatin decondensation. The NTAD demonstrated moderate 
transactivation when targeted to a promoter proximal position but showed little activity 
from more distal positions and on a natural promoter. By contrast, NTAD dramatically 
decondensed the compact chromatin structure of a large transgene array, in a manner 
similar to the potent activation domain in VP16. In addition, NTAD is subject to 
conjugation by SUMO, which reduced its transcriptional and chromatin opening activity.  
Moreover, mimicking full sumoylation by fusing Sumo-1 or -3 to the activation domain 
eliminated its transcriptional activity, but only Sumo-3 fusion prevented chromatin 
opening.  The activation domain‟s limited transactivation, but strong chromatin 
decondensation likely allows CTCF to establish and maintain open chromatin without 
necessarily activating transcription.  In future work, we are evaluating the NTAD to 
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determine its related family of activation motifs and have begun looking at endogenous 
loci, like the Igf2/H19 ICR, for associations with chromatin-opening cofactors like 
Brahma and Gcn5.     
In chapter 3, we showed that CTCF induced large scale unfolding of a large 
transgene array‟s compact chromatin almost as effectively as enhancer factors.  Deletion 
analysis revealed that along with the NTAD, two domains in its C-terminal region were 
sufficient to decondense the array, and each appeared to open the array with different but 
overlapping sets of chromatin modifying proteins.  As an activation domain, the N-
terminal domain recruited chromatin remodeling proteins (brahma, Mi-2) and histone 
acetyltransferases (p300, Gcn5, Tip60) to the array and induced histone hyperacetylation.  
It also recruited several subunits of the cohesin complex, which has been implicated in 
both the tethering and enhancer blocking activity of CTCF.  The two domains in CTCF‟s 
C-terminal region recruited chromatin remodeling proteins (brahma, Chd8, Mi-2), but did 
not induce histone hyperacetylation. We also showed that CTCF‟s putative AT-hook 
altered the large-scale structure of the decondensed array in a manner that suggests it is 
tethering distant chromatin regions together.  Our results with the array suggest that three 
separate domains in CTCF are sufficient to initiate decondensation of chromatin 
structure.  Moreover, we also uncovered the first evidence that a transcriptional activation 
domain can recruit cohesin, which provides a link between open chromatin, tethering, 
and enhancer blocking.  We also have preliminary evidence that the cohesin complex is 
recruited by other activation domains like p65.  While the cohesin complex has already 
been shown at CTCF sites, not all cohesin complex binding sites overlap with CTCF.  
Thus, it will be very interesting to see if the cohesin complex has a more dynamic role 
with chromatin at active gene regions. 
In chapter 4, we determined that the C-terminal portion of CTCF harbors 
enhancer blocking activity and that sumoylation domain within this region (675-721) 
significantly contributes to this activity.  The sumoylation domains demonstrated potent 
blocking activity when directly fused to the activation domain of p65 and this activity 
was position-dependent, the defining characteristic of an enhancer blocker.  By contrast, 
neither the NTAD nor the PARlation domain NT-P contributed to the enhancer blocking 
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activity.  Mutating the sumoylation sites removed most of the enhancer blocking activity, 
although an Ubc9-binding motif also contributes to this activity.  We suggest that the 
subpopulation of sumoylated CTCF likely targets the specific loci where CTCF‟s 
enhancer blocking activity is required and that this post-translational modification 
contributes to the recruitment of repression machinery involved in blocking enhancers.  
Testing 675-721‟s EB activity at endogenous loci and showing recruitment of SUMO 
protein to these sites will be essential to clarifying its role in insulator function.  
Moreover, the CoREST complex does not appear to be involved with blocking, so 
elucidating the protein cofactors involved with SUMO and Ubc9 will be of interest.    
In addition to this work, significant studies using genome-wide tools, the 3C 
assay, and other refined tools have established CTCF as a prominent protein in the 
maintenance of the nuclear architecture.  Our understanding of the nucleus has grown 
exponentially over the past decades and most recently, we are beginning to understand 
the nucleus in a 3-dimensional context.  CTCF plays a vital role in today‟s models of 
nuclear architecture and genome regulation.  CTCF is thought to help maintain the 
integrity of chromatin structure and establish sub-nuclear domains for specific regulation.  
While the mechanism is still not fully understood, key properties have been identified in 
this process.  CTCF‟s ability to open chromatin is likely essential to its function and 
sumoylation of CTCF likely targets a subpopulation of CTCF protein to enhancer 
blocking sites.  For example, at the well-studied Igf2/H19 locus, CTCF has been shown 
to be essential in enhancer blocking and chromatin-loop formation, which likely involves 
chromatin opening machinery and sumoylation regulation (Figure 2).  Further 
characterization at this endogenous locus and other loci will be instrumental in validating 
these finds and further clarifying the mechanism by which CTCF “weaves” the 
meshwork of nuclear structure. 
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FIGURES 
 
 
Figure 5.1 Summary of the functional domains identified and clarified during the course of this 
work.  CTCF domains characterized in 2002 are show in the top schematic.  The bottom schematic 
identifies domains characterized during the course of this study: NTAD (yellow) has chromatin opening 
and transactivation activities and associates with the cohesin complex.  Two domains in the CT open 
chromatin (green and purple) with the purple domain also acting as an enhancer blocker.  The AT-hook 
motif, CHD8 domain and SUMO sites (red bars) are listed.   
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Figure 5.2 A 3D model for how CTCF regulates the Igf2/H19 maternal locus.  (A) A linear model for 
CTCF binding at the ICR of the Igf2/H19 locus, with arrows indicating chromatin looping associations.  
(B) A 3D model of the same locus with looped-domains and suggested protein associations with each loop.  
Sumoylated CTCF is indicated by red stars.  
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